<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01468701</url>
  </required_header>
  <id_info>
    <org_study_id>1160.129</org_study_id>
    <nct_id>NCT01468701</nct_id>
  </id_info>
  <brief_title>GLORIA-AF Registry Program - Second and Third Phases</brief_title>
  <official_title>GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boehringer Ingelheim</source>
  <brief_summary>
    <textblock>
      In this part of the Registry Program patients with non-valvular atrial fibrillation (AF) at&#xD;
      risk for stroke are enrolled to characterize the target population and to collect real world&#xD;
      data on important outcome events. For administrative purposes the study is divided into two&#xD;
      protocol numbers: 1160.129 for all non-EU (European Union) and non-EEA (European Economic&#xD;
      Area) countries, and 1160.136 for EU and EEA countries. The total number of patients enrolled&#xD;
      in both protocols is estimated to be 48,000 patients, and all these patients will be included&#xD;
      in the data analysis for study 1160.129.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 7, 2011</start_date>
  <completion_date type="Actual">January 10, 2020</completion_date>
  <primary_completion_date type="Actual">January 10, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence Rate of Composite Outcome (Stroke, Systemic Embolism, Myocardial Infarction, Life-threatening Bleeding Events and Vascular Death) - Phase II</measure>
    <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
    <description>Incidence rate of composite outcome which includes events of Stroke, systemic embolism, myocardial infarction, life-threatening bleeding events and vascular death on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only. In case of multiple events for a patient, the first event was considered.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Composite Outcome (Stroke, Systemic Embolism, Myocardial Infarction, Life-threatening Bleeding Events and Vascular Death) - Phase III</measure>
    <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
    <description>Incidence rate of composite outcome which includes events of Stroke, systemic embolism, myocardial infarction, life-threatening bleeding events and vascular death on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. In case of multiple events for a patient, the first event was considered. Unknown cause of death was imputed by multiple imputation. Counts were based on the average of the 20 restricted data sets. The average of the 20 incidence rates from the 20 imputed datasets were used to obtain the point estimate of the incidence rate that is reported here. The bootstrapping approach was used to obtain the 95% confidence interval of the incidence rate.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Vascular Composite Outcome (Stroke, Systemic Embolism, Myocardial Infarction and Vascular Death) - Phase II</measure>
    <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
    <description>Incidence rate of vascular composite outcome including events of stroke, systemic embolism, myocardial infarction and vascular death on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only. In case of multiple events for a patient, the first event was considered.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Vascular Composite Outcome (Stroke, Systemic Embolism, Myocardial Infarction and Vascular Death) - Phase III</measure>
    <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
    <description>Incidence rate of vascular composite outcome including events of stroke, systemic embolism, myocardial infarction and vascular death on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. In case of multiple events for a patient, the first event was considered. Unknown death was imputed by multiple imputation. Counts were based on the average of the 20 restricted data sets. The average of the 20 incidence rates from the 20 imputed datasets were used to obtain the point estimate of the incidence rate that is reported here. The bootstrapping approach was used to obtain the 95% confidence interval of the incidence rate.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Stroke or Systemic Embolism - Phase III</measure>
    <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
    <description>Incidence rate of stroke or systemic embolism on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Stroke - Phase II</measure>
    <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
    <description>Incidence rate of stroke on all eligible patients excluding prescribed but not taken set for Dabigatran etexilate (DE) of phase II only is presented. Stroke is an acute onset of a focal neurological deficit of presumed vascular origin lasting for 24 hours or more or resulting in death. The stroke included ischemic or hemorrhagic or uncertain classification.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Stroke - Phase III</measure>
    <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
    <description>Incidence rate of stroke on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. Stroke is an acute onset of a focal neurological deficit of presumed vascular origin lasting for 24 hours or more or resulting in death. The stroke included ischemic or hemorrhagic or uncertain classification.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Transient Ischaemic Attack (TIA) - Phase II</measure>
    <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
    <description>Incidence rate of transient ischaemic attack (TIA) on on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Transient Ischaemic Attack (TIA) - Phase III</measure>
    <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
    <description>Incidence rate of transient ischaemic attack (TIA) on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Systemic Embolism (SE) - Phase II</measure>
    <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
    <description>Incidence rate of systemic embolism (SE) on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Systemic Embolism (SE) - Phase III</measure>
    <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
    <description>Incidence rate of systemic embolism (SE) on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Pulmonary Embolism (PE) - Phase II</measure>
    <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
    <description>Incidence rate of pulmonary embolism (PE) on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Pulmonary Embolism (PE) - Phase III</measure>
    <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
    <description>Incidence rate of pulmonary embolism (PE) on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Major Bleeding Events (MBE) - Phase II</measure>
    <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
    <description>Incidence rate of major bleeding events (MBE) on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented. Major bleeding was defined as meeting one or more of the following criteria: Overt bleeding associated with a reduction in haemoglobin of at least 20 grams per liter or leading to a transfusion of at least 2 units of blood or packed cells; Symptomatic bleeding in a critical area or organ: Intraocular, intracranial, intraspinal or intramuscular with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding or pericardial bleeding; Life-threatening bleeding.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Major Bleeding Events (MBE) - Phase III</measure>
    <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
    <description>Incidence rate of major bleeding events on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. Major bleeding was defined as meeting one or more of the following criteria: Overt bleeding associated with a reduction in haemoglobin of at least 20 grams per liter or leading to a transfusion of at least 2 units of blood or packed cells; Symptomatic bleeding in a critical area or organ: Intraocular, intracranial, intraspinal or intramuscular with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding or pericardial bleeding; Life-threatening bleeding.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Life-threatening Bleeding Events - Phase II</measure>
    <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
    <description>Incidence rate of life-threatening bleeding events on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented. Life-threatening bleeding was defined as meeting one or more of the following criteria: Symptomatic intracranial bleed; Reduction in haemoglobin of at least 50 grams per liter; Transfusion of at least 4 units of blood or packed cells, associated with hypotension requiring the use of intravenous inotropic agents; Necessitated surgical intervention; Fatal bleeding.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Life-threatening Bleeding Events - Phase III</measure>
    <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
    <description>Incidence rate of life-threatening bleeding events on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. Life-threatening bleeding was defined as meeting one or more of the following criteria: Symptomatic intracranial bleed; Reduction in haemoglobin of at least 50 grams per liter; Transfusion of at least 4 units of blood or packed cells, associated with hypotension requiring the use of intravenous inotropic agents; Necessitated surgical intervention; Fatal bleeding.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Myocardial Infarction (MI) - Phase II</measure>
    <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
    <description>Incidence rate of myocardial infarction (MI) on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Myocardial Infarction (MI) - Phase III</measure>
    <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
    <description>Incidence rate of myocardial infarction on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of All-cause Death - Phase II</measure>
    <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
    <description>Incidence rate of all-cause death on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of All-cause Death - Phase III</measure>
    <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
    <description>Incidence rate of all-cause death on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Vascular Death - Phase II</measure>
    <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
    <description>Incidence rate of vascular death on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of Vascular Death - Phase III</measure>
    <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
    <description>Incidence rate of vascular death on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
  </primary_outcome>
  <enrollment type="Actual">37235</enrollment>
  <condition>Stroke</condition>
  <condition>Atrial Fibrillation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with non-valvular AF&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          1. Age =&gt;18 years at enrollment&#xD;
&#xD;
          2. Male or female patient (or legally acceptable representative) willing and able to&#xD;
             provide written informed consent&#xD;
&#xD;
          3. Patient newly diagnosed (&lt; 3 months prior to baseline visit) with non-valvular AF and&#xD;
             at risk for stroke.&#xD;
&#xD;
        Other inclusion criteria apply.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. Presence of any mechanical heart valve, or valve disease that is expected to require&#xD;
             valve replacement intervention;&#xD;
&#xD;
          2. Patients who have received more than 60 days of vitamin K antagonist (VKA) treatment&#xD;
             in their lifetime;&#xD;
&#xD;
          3. AF with a generally reversible cause;&#xD;
&#xD;
          4. Patients with a medical condition other than atrial fibrillation for which chronic use&#xD;
             of an oral anticoagulant (for example, a VKA) is indicated Other exclusion criteria&#xD;
             apply&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boehringer Ingelheim</last_name>
    <role>Study Chair</role>
    <affiliation>Boehringer Ingelheim</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University South Alabama Medical Center</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>38817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Black Warrior Research</name>
      <address>
        <city>Northport</city>
        <state>Alabama</state>
        <zip>35476</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scottsboro Quick Care Clinic</name>
      <address>
        <city>Scottsboro</city>
        <state>Alabama</state>
        <zip>35768</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alaska Heart Institute</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phoenix Heart PLLC</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85306</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Cinic Hot Springs Communities</name>
      <address>
        <city>Hot Springs</city>
        <state>Arizona</state>
        <zip>71913</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwest Internal Medicine, PLLC</name>
      <address>
        <city>Lake Havasu City</city>
        <state>Arizona</state>
        <zip>86403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sparks Regional Medical Center</name>
      <address>
        <city>Fort Smith</city>
        <state>Arkansas</state>
        <zip>72901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Michael A. Frais, Cardiologist, P.A.</name>
      <address>
        <city>Hot Springs</city>
        <state>Arkansas</state>
        <zip>71913</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology and Medicine Clinic</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Donald W. Reynolds Institute on Aging</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205-7199</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Cardiology, PA</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diagnamics, Inc</name>
      <address>
        <city>Encinitas</city>
        <state>California</state>
        <zip>92024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allianz Medical and Research Center</name>
      <address>
        <city>Fountain Valley</city>
        <state>California</state>
        <zip>92708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>B&amp;K Medical Research Center</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93721</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>American Clinical Trials</name>
      <address>
        <city>Hawaiian Gardens</city>
        <state>California</state>
        <zip>90716</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scripps Clinic</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>La Mesa Cardiac Center</name>
      <address>
        <city>La Mesa</city>
        <state>California</state>
        <zip>91942</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Los Alamitos Cardiovascular</name>
      <address>
        <city>Los Alamitos</city>
        <state>California</state>
        <zip>90720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Greater Los Angeles Healthcare System</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mehrdad Kevin Ariani, MD, Incorporated</name>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <zip>91325</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisenhower Desert Cardiology Center</name>
      <address>
        <city>Rancho Mirage</city>
        <state>California</state>
        <zip>92270</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ritchken and First MD's</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coastal Heart Group Inc</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pacific Heart and Vascular</name>
      <address>
        <city>Stockton</city>
        <state>California</state>
        <zip>95210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southwest Heart Institute</name>
      <address>
        <city>Temecula</city>
        <state>California</state>
        <zip>92591</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California Los Angeles</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90509</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates Medical Group Inc</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ventura Cardiology Consultants Medical Group, Inc</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ventura Clinical Trials</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Office of Dr. David J Cislowski MD</name>
      <address>
        <city>Visalia</city>
        <state>California</state>
        <zip>93291</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora Denver Cardiology Associates, PC</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lynn Institute of the Rockies</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80909</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pikes Peak Cardiology</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80909</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Denver Health Medical Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Denver Cardiology Associates, PC</name>
      <address>
        <city>Littleton</city>
        <state>Colorado</state>
        <zip>80120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Connecticut Clinical Research, LLC</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <zip>06606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Connecticut Heart and Vascular Center</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <zip>06606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bridgeport Hospital</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <zip>06610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of Fairfield County</name>
      <address>
        <city>Norwalk</city>
        <state>Connecticut</state>
        <zip>06851</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norwalk Medical Group</name>
      <address>
        <city>Norwalk</city>
        <state>Connecticut</state>
        <zip>06851</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Specialists, PC of Southern CT</name>
      <address>
        <city>Shelton</city>
        <state>Connecticut</state>
        <zip>06484</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Red Clay Research LLC.</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Howard University Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiac Arrhythmia Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Faculty Associates, Inc</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aventura Institute for Cardiovascular Wellness, PA</name>
      <address>
        <city>Aventura</city>
        <state>Florida</state>
        <zip>33180</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bay Area Cardiology</name>
      <address>
        <city>Brandon</city>
        <state>Florida</state>
        <zip>33511</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampa Bay Medical Research</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33761</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seidman Clinical Trials</name>
      <address>
        <city>Delray Beach</city>
        <state>Florida</state>
        <zip>33484</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universal Clinical Research Associates</name>
      <address>
        <city>Doral</city>
        <state>Florida</state>
        <zip>33166</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Research of North Florida LLC</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Magi Research Clinic, Inc</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Global Research Solutions Corporation</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Ambulatory Care</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tenet Florida Physician Services</name>
      <address>
        <city>Jupiter</city>
        <state>Florida</state>
        <zip>33458</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Watson Clinic Center for Research, Inc</name>
      <address>
        <city>Lakeland</city>
        <state>Florida</state>
        <zip>33805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A&amp;L Clinical Research</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33126</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Center for Cardiovascular Disease</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Global Research Solutions Corporation</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Research Center of South Florida</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33173</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Horizon Research Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33175</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sacred Heart Medical Specialty Group</name>
      <address>
        <city>Miramar Beach</city>
        <state>Florida</state>
        <zip>32550</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Collier HMA Physician Management</name>
      <address>
        <city>Naples</city>
        <state>Florida</state>
        <zip>34119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Edgewater Medical Research</name>
      <address>
        <city>New Smyrna Beach</city>
        <state>Florida</state>
        <zip>32169</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SouthEast Medical Centre</name>
      <address>
        <city>Oakland Park</city>
        <state>Florida</state>
        <zip>33309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research One</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Florida Research Solutions, LLC</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33028</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Langhorne Cardiology Consultants, Inc</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VNH Heart Center Research</name>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <zip>33952</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brevard Cardiovascular Research Associates, Inc</name>
      <address>
        <city>Rockledge</city>
        <state>Florida</state>
        <zip>32955</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Suncoast Cardiovascular Research Inc.</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northside Hospital</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33709</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alternative Solutions Medical Research and Prevention Center</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33711</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Velella Research, Inc</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Center of Sarasota</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James C. Neiman, MD</name>
      <address>
        <city>Seminole</city>
        <state>Florida</state>
        <zip>33772</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tallahassee Research Instutite</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indian River Medical Associates Cardiology</name>
      <address>
        <city>Vero Beach</city>
        <state>Florida</state>
        <zip>32960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Partners Clinical Research Institute</name>
      <address>
        <city>Wellington</city>
        <state>Florida</state>
        <zip>33449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Executive Health and Research Associates</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph's Research Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atlanta Heart Specialists, LLC</name>
      <address>
        <city>Cumming</city>
        <state>Georgia</state>
        <zip>30041</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William C McGarity, Jr, MD, PC</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coliseum Medical Center</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31217</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kootenai Heart Clinics, LLC</name>
      <address>
        <city>Coeur d'Alene</city>
        <state>Idaho</state>
        <zip>83814</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Heart Clinical Research, LLC</name>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <zip>60005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prairie Cardiovascular Memorial Hospital</name>
      <address>
        <city>Carbondale</city>
        <state>Illinois</state>
        <zip>62901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Captain James A. Lovell Federal Health Care Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60064</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medex Healthcare Research</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John H. Stroger Jr. Hospital of Cook Country</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore Cardiology Consultants</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60631</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Heart Care, LLC, Medicoricum, LLC</name>
      <address>
        <city>Fairview Heights</city>
        <state>Illinois</state>
        <zip>62208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Adventist Health Partners, Inc</name>
      <address>
        <city>Hinsdale</city>
        <state>Illinois</state>
        <zip>60521</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Consultants in Cardiovascular Medicine</name>
      <address>
        <city>Melrose Park</city>
        <state>Illinois</state>
        <zip>60160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Koch Family Medicine</name>
      <address>
        <city>Morton</city>
        <state>Illinois</state>
        <zip>61550</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Cardiovascular Consultants</name>
      <address>
        <city>Rock Island</city>
        <state>Illinois</state>
        <zip>61201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DuPage Medical Group</name>
      <address>
        <city>Winfield</city>
        <state>Illinois</state>
        <zip>60190</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hendricks Family Medicine</name>
      <address>
        <city>Brownsburg</city>
        <state>Indiana</state>
        <zip>46112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parkview Research Center</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46845</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Medical Group</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beacon Medical Group Clinical Research</name>
      <address>
        <city>LaPorte</city>
        <state>Indiana</state>
        <zip>46350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of Northwest Indiana, PC</name>
      <address>
        <city>Munster</city>
        <state>Indiana</state>
        <zip>46321</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beacon Medical Group Clinical Research</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McFarland Clinic PC</name>
      <address>
        <city>Ames</city>
        <state>Iowa</state>
        <zip>50010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northeast Iowa Medical Education Foundation</name>
      <address>
        <city>Waterloo</city>
        <state>Iowa</state>
        <zip>50702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Iowa Clinic, PC</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50266</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwest Heart and Vascular Specialists</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Cardiology Associates</name>
      <address>
        <city>Elizabethtown</city>
        <state>Kentucky</state>
        <zip>42701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Robley Rex VA Medical Center</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Health Clinical Studies</name>
      <address>
        <city>Madisonville</city>
        <state>Kentucky</state>
        <zip>42431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Office of Dr. Paul McLaughlin, M.D.</name>
      <address>
        <city>Mount Sterling</city>
        <state>Kentucky</state>
        <zip>40353</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Integrity, LLC</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cambridge Medical Trials</name>
      <address>
        <city>Alexandria</city>
        <state>Louisiana</state>
        <zip>71301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Research Foundation of Louisiana</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grace Research, LLC</name>
      <address>
        <city>Bossier City</city>
        <state>Louisiana</state>
        <zip>71111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Clinic of Hammond</name>
      <address>
        <city>Hammond</city>
        <state>Louisiana</state>
        <zip>70403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Specialists of Southwest Louisiana, LLC</name>
      <address>
        <city>Lake Charles</city>
        <state>Louisiana</state>
        <zip>70601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medpharmics, LLC</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LSU Health Sciences Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Cardiovascular Specialists</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Louisiana Heart Center</name>
      <address>
        <city>Slidell</city>
        <state>Louisiana</state>
        <zip>70458</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Maine Health Care</name>
      <address>
        <city>Biddeford</city>
        <state>Maine</state>
        <zip>04005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiac Consultants, LLC</name>
      <address>
        <city>Annapolis</city>
        <state>Maryland</state>
        <zip>21401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Health Research Institute</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Southern Maryland Hospital Center</name>
      <address>
        <city>Clinton</city>
        <state>Maryland</state>
        <zip>20735</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Specialists of Central Maryland</name>
      <address>
        <city>Columbia</city>
        <state>Maryland</state>
        <zip>21044</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Delmarva Heart Research Foundation, Inc</name>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <zip>21804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peninsula Cardiology Associates</name>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <zip>21804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chesapeake Cardiovascular Associates</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Primary Care Cardiology Research, Inc</name>
      <address>
        <city>Ayer</city>
        <state>Massachusetts</state>
        <zip>01432</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genesys Research Institute, Incorporated</name>
      <address>
        <city>Brighton</city>
        <state>Massachusetts</state>
        <zip>02135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NECCR Internal Med and Cardio</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newton-Wellesley Hospital</name>
      <address>
        <city>Newton</city>
        <state>Massachusetts</state>
        <zip>02462</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endeavor Medical Research</name>
      <address>
        <city>Alpena</city>
        <state>Michigan</state>
        <zip>49707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McLaren Bay Region Medical Center</name>
      <address>
        <city>Bay City</city>
        <state>Michigan</state>
        <zip>48708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital K-15</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Consultants in Cardiovascular Disease, LLC</name>
      <address>
        <city>Erie</city>
        <state>Michigan</state>
        <zip>16502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants of East Michigan</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48532</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genesys Heart Institute</name>
      <address>
        <city>Grand Blanc</city>
        <state>Michigan</state>
        <zip>48439</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Cardiology Associates</name>
      <address>
        <city>Grand Blanc</city>
        <state>Michigan</state>
        <zip>48439</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thoracic and Cardiovascular Healthcare Foundation</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48910</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Upper Michigan Cardiovascular Associates, PC</name>
      <address>
        <city>Marquette</city>
        <state>Michigan</state>
        <zip>49855</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McLaren-Macomb</name>
      <address>
        <city>Mount Clemens</city>
        <state>Michigan</state>
        <zip>48043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Western Medical Clinic</name>
      <address>
        <city>Niles</city>
        <state>Michigan</state>
        <zip>49120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Park Hospital</name>
      <address>
        <city>Novi</city>
        <state>Michigan</state>
        <zip>48374</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Covenant Medical Center, Inc.</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MId-MIchigan Heart and Vascular Center</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Essentia Heart and Vascular Clinic</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minneapolis Heart Institute Foundation</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CentraCare Heart and Vascular Center</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>United Heart and Vascular Clinic</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Center for Clinical Trials, Inc.</name>
      <address>
        <city>Biloxi</city>
        <state>Mississippi</state>
        <zip>39531</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Midwest Ventures Group, Inc</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heartland Regional Medical Center</name>
      <address>
        <city>Saint Joseph</city>
        <state>Missouri</state>
        <zip>64506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Louis University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Consult and Research Associates</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gateway Cardiology, PC</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kalispell Regional Medical Center</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MidAmerica Cardiovascular Institute</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meridian Clinical Research, LLC</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Board of Regents of the University of Nebraska</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198-7835</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alegent Health Heart and Vascular Specialists</name>
      <address>
        <city>Papillion</city>
        <state>Nebraska</state>
        <zip>68046</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Renown Institute for Heart and Vascular Health</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Sierra Nevada Health Care System</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medicor Cardiology</name>
      <address>
        <city>Bridgewater</city>
        <state>New Jersey</state>
        <zip>08807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Monmouth Cardiology Associates</name>
      <address>
        <city>Eatontown</city>
        <state>New Jersey</state>
        <zip>07724</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Electrophysiology Associates of Northern New Jersey</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advocare Heights Primary Care</name>
      <address>
        <city>Haddon Heights</city>
        <state>New Jersey</state>
        <zip>08035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Associated Cardiovascular Consultants Lourdes</name>
      <address>
        <city>Hammonton</city>
        <state>New Jersey</state>
        <zip>08037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NJ Heart LLC</name>
      <address>
        <city>Linden</city>
        <state>New Jersey</state>
        <zip>07036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Garden State Heart Care, PC</name>
      <address>
        <city>Manalapan</city>
        <state>New Jersey</state>
        <zip>07726</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atlantic Cardiology, LLC</name>
      <address>
        <city>Neptune</city>
        <state>New Jersey</state>
        <zip>07753</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rutgers Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph's Regional Medical Center</name>
      <address>
        <city>Paterson</city>
        <state>New Jersey</state>
        <zip>07503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Valley Hospital</name>
      <address>
        <city>Ridgewood</city>
        <state>New Jersey</state>
        <zip>07450</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart and Vascular Center of New Brunswick</name>
      <address>
        <city>Somerset</city>
        <state>New Jersey</state>
        <zip>08873</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central New Jersey Cardiology</name>
      <address>
        <city>South Plainfield</city>
        <state>New Jersey</state>
        <zip>07080</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Associated Cardiovascular Consultants Lourdes</name>
      <address>
        <city>Voorhees</city>
        <state>New Jersey</state>
        <zip>08043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NJ Cardiology Associates</name>
      <address>
        <city>West Orange</city>
        <state>New Jersey</state>
        <zip>07052</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lovelace Scientific Resources, Inc.</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center / Albany Medical College</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiac Care and Vascular Medicine, PLLC</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10469</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York -Presbyterian Brooklyn Methodist Hospital</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Cardiology</name>
      <address>
        <city>Camillus</city>
        <state>New York</state>
        <zip>13031</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bassett Medical Center</name>
      <address>
        <city>Cooperstown</city>
        <state>New York</state>
        <zip>13326</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Hospital Queens</name>
      <address>
        <city>Flushing</city>
        <state>New York</state>
        <zip>11355</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UHS Office of Clinical Trials</name>
      <address>
        <city>Johnson City</city>
        <state>New York</state>
        <zip>13790</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Island Heart Associates</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chinatown Cardiology, PC</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Luke - Roosevelt Hospital Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saratoga Clinical Research, LLC</name>
      <address>
        <city>Saratoga Springs</city>
        <state>New York</state>
        <zip>12866</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stony Brook Cardiology/Electrophysiology</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794-8167</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Heart Center</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Great Lakes Medical Research</name>
      <address>
        <city>Westfield</city>
        <state>New York</state>
        <zip>14787</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Group of Western New York, PC</name>
      <address>
        <city>Williamsville</city>
        <state>New York</state>
        <zip>14221</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kernodle Clinic West</name>
      <address>
        <city>Burlington</city>
        <state>North Carolina</state>
        <zip>27215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trials of America, Inc</name>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <zip>28601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Cardiology Cornerstone</name>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <zip>27262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Profen Research Network at East Carolina Medical Associates</name>
      <address>
        <city>Jacksonville</city>
        <state>North Carolina</state>
        <zip>28546</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kannapolis Internal Medicine</name>
      <address>
        <city>Kannapolis</city>
        <state>North Carolina</state>
        <zip>28083</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trials of America, Inc</name>
      <address>
        <city>Lenoir</city>
        <state>North Carolina</state>
        <zip>28645</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pinehurst Medical Clinic, Inc</name>
      <address>
        <city>Pinehurst</city>
        <state>North Carolina</state>
        <zip>28374</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Heart Research</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Heart and Vascular Associates</name>
      <address>
        <city>Wilson</city>
        <state>North Carolina</state>
        <zip>27893</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lillestol Research, LLC</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trinity Health Center Medical Arts</name>
      <address>
        <city>Minot</city>
        <state>North Dakota</state>
        <zip>58701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aultman Hospital</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The MetroHealth System</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109-1998</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Health Fairfield Hospital</name>
      <address>
        <city>Fairfield</city>
        <state>Ohio</state>
        <zip>45014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Cardiovascular Research Foundation</name>
      <address>
        <city>Fairview Park</city>
        <state>Ohio</state>
        <zip>44126</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emil Hayek, M.D., Inc</name>
      <address>
        <city>Hudson</city>
        <state>Ohio</state>
        <zip>44236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Innovation Center, Kettering Medical Center</name>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <zip>45429</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>RAS Health Ltd</name>
      <address>
        <city>Marion</city>
        <state>Ohio</state>
        <zip>43302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frederick C Smith Clinic Inc</name>
      <address>
        <city>Marion</city>
        <state>Ohio</state>
        <zip>43342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mound Family Practice</name>
      <address>
        <city>Miamisburg</city>
        <state>Ohio</state>
        <zip>45342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart House Research Foundation, LLC</name>
      <address>
        <city>Springfield</city>
        <state>Ohio</state>
        <zip>45504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Research Center</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toledo Clinic Incorporated</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43623</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Great Lakes Medical Research, LLC</name>
      <address>
        <city>Willoughby</city>
        <state>Ohio</state>
        <zip>44094</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio Heart Institute</name>
      <address>
        <city>Youngstown</city>
        <state>Ohio</state>
        <zip>44504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma Foundation for Cardiovascular Research</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>INTEGRIS Ambulatory Care Corporation</name>
      <address>
        <city>Yukon</city>
        <state>Oklahoma</state>
        <zip>73099</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital Corvallis</name>
      <address>
        <city>Corvallis</city>
        <state>Oregon</state>
        <zip>97330</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fanno Creek Clinic, LLC</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sacred Heart Medical Center at RiverBend</name>
      <address>
        <city>Springfield</city>
        <state>Oregon</state>
        <zip>97477</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abington Medical Specialists</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <zip>19003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capital Area Research, LLC</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Preferred Primary Care Phys</name>
      <address>
        <city>Carnegie</city>
        <state>Pennsylvania</state>
        <zip>15106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chambersburg Hospital</name>
      <address>
        <city>Chambersburg</city>
        <state>Pennsylvania</state>
        <zip>17201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Bucks Cardiology</name>
      <address>
        <city>Doylestown</city>
        <state>Pennsylvania</state>
        <zip>18901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Physician Specialist of Northern Lancaster County Medcl Grp</name>
      <address>
        <city>Ephrata</city>
        <state>Pennsylvania</state>
        <zip>17522</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harleysville Medical Associates</name>
      <address>
        <city>Harleysville</city>
        <state>Pennsylvania</state>
        <zip>19438</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lycoming Internal Medicine, Inc</name>
      <address>
        <city>Jersey Shore</city>
        <state>Pennsylvania</state>
        <zip>17740</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants of Philadelphia</name>
      <address>
        <city>Lansdale</city>
        <state>Pennsylvania</state>
        <zip>19446-3748</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104-6205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pennsylvania Cardiology Associates</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Einstein Medical Center Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allegheny Neurology Associates</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grand View - Lehigh Valley Health Services</name>
      <address>
        <city>Sellersville</city>
        <state>Pennsylvania</state>
        <zip>18960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Warminster Medical Associates, PC</name>
      <address>
        <city>Warminster</city>
        <state>Pennsylvania</state>
        <zip>18974</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants of Philadelphia</name>
      <address>
        <city>Yardley</city>
        <state>Pennsylvania</state>
        <zip>19067</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital of RI</name>
      <address>
        <city>Pawtucket</city>
        <state>Rhode Island</state>
        <zip>02860</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South County Cardiology</name>
      <address>
        <city>Wakefield</city>
        <state>Rhode Island</state>
        <zip>02879</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AnMed Health Clinical Research</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Internal Medicine Associates of Anderson, PA</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lowcountry Medical Group, LLC</name>
      <address>
        <city>Beaufort</city>
        <state>South Carolina</state>
        <zip>29906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Carolina Heart Center</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Cardiology Associates, P.A.</name>
      <address>
        <city>Greenwood</city>
        <state>South Carolina</state>
        <zip>29646</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Medicine of SayeBrook</name>
      <address>
        <city>Myrtle Beach</city>
        <state>South Carolina</state>
        <zip>29588</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Black Hills Cardiovascular Research</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Office of Yvonne Chester</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Jackson Clinic, PA</name>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>38301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center For Cardiovascular Research</name>
      <address>
        <city>Johnson City</city>
        <state>Tennessee</state>
        <zip>37604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Knoxville</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tennova Healthcare-Turkey Creek Medical Center</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37934</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Knoxville</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37938</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>THV Research, LLC</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78745</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southeast Texas Clinical Research Center</name>
      <address>
        <city>Beaumont</city>
        <state>Texas</state>
        <zip>77702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dallas VA Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heartplace</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-8837</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amir Malik Research</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State of the Heart Cardiology</name>
      <address>
        <city>Grapevine</city>
        <state>Texas</state>
        <zip>76051</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Angiocardiac Care of Texas</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Houston Methodist DeBakey Cardiology Associates</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barry Troyan, M.D, PA</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centex Studies, Inc.</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77062</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dairy Ashford Family Pratice</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77077</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates PLLC</name>
      <address>
        <city>Humble</city>
        <state>Texas</state>
        <zip>77338</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Center of Houston, PA</name>
      <address>
        <city>Katy</city>
        <state>Texas</state>
        <zip>77450</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Cardiology Research Center PLLC</name>
      <address>
        <city>Kingwood</city>
        <state>Texas</state>
        <zip>77339</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Caprock Cardiac Center Research Institute</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79410</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mission Research Institute, LLC</name>
      <address>
        <city>New Braunfels</city>
        <state>Texas</state>
        <zip>78130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercury Medical ,LLC</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Medical Research Associates</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78238</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sealy Urgent Care Center and Medical Clinic</name>
      <address>
        <city>Sealy</city>
        <state>Texas</state>
        <zip>77474</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seguin Institute of Cardiovascular Research</name>
      <address>
        <city>Seguin</city>
        <state>Texas</state>
        <zip>78155</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sugarland Cardiology</name>
      <address>
        <city>Sugar Land</city>
        <state>Texas</state>
        <zip>77479</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of East Texas, PA</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trinity Clinic</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at Tyler</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Health Services of Waco</name>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <zip>76712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hill County Primary Care</name>
      <address>
        <city>Whitney</city>
        <state>Texas</state>
        <zip>76692</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Center at Saint Mark's</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Highland Clinical Research</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Burke Internal Medicine and Research</name>
      <address>
        <city>Burke</city>
        <state>Virginia</state>
        <zip>22015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates, Ltd</name>
      <address>
        <city>Chesapeake</city>
        <state>Virginia</state>
        <zip>23320</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants of Danville, Inc</name>
      <address>
        <city>Danville</city>
        <state>Virginia</state>
        <zip>24541</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inova Research Center</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Heart</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mary Washington Hospital Research Department</name>
      <address>
        <city>Fredericksburg</city>
        <state>Virginia</state>
        <zip>22401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harrisonburg Medical Associates</name>
      <address>
        <city>Harrisonburg</city>
        <state>Virginia</state>
        <zip>22801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manassas Clinical Research Center</name>
      <address>
        <city>Manassas</city>
        <state>Virginia</state>
        <zip>20110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of Virginia</name>
      <address>
        <city>Midlothian</city>
        <state>Virginia</state>
        <zip>23114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CJW Medical Center - Chippenham</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carilion Clinic</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Salem VA Medical Center</name>
      <address>
        <city>Salem</city>
        <state>Virginia</state>
        <zip>24153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Selma Medical Associates, Winchester</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sound Medical Research</name>
      <address>
        <city>Port Orchard</city>
        <state>Washington</state>
        <zip>98366</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Polyclinic</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98133</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Franciscan Heart and Vascular Associates</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiac and Thoracic Institute of Central Washington</name>
      <address>
        <city>Yakima</city>
        <state>Washington</state>
        <zip>98902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CAMC Clinical Trials Center</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Cardiovascular Services</name>
      <address>
        <city>Huntington</city>
        <state>West Virginia</state>
        <zip>25701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary's Medical Center</name>
      <address>
        <city>Huntington</city>
        <state>West Virginia</state>
        <zip>25702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic-Sparta</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <zip>54601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karim Bakhtiar MD, SC</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Medical Clinic</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wheaton Franciscan</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53221</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Milwaukee VA Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53295</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ProHealth Care Research Institute and Cardiology Associates</name>
      <address>
        <city>Waukesha</city>
        <state>Wisconsin</state>
        <zip>53188</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Consultorios Hematologicos SRL</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1188</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Coronel Surez</name>
      <address>
        <city>Buenos Aires</city>
        <zip>B7540GHD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Italiano de Buenos Aires</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1181ACH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Cardiovascular de Buenos Aires</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1428</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Cardiovascular de Corrientes Juana Francisca Cabra</name>
      <address>
        <city>Corrientes</city>
        <zip>C3400</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Espanol de Mendonza</name>
      <address>
        <city>Godoy Cruz</city>
        <zip>5501</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Privado de Comunidad</name>
      <address>
        <city>Mar del Plata</city>
        <zip>7602</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DIM Clinica Privada</name>
      <address>
        <city>Ramos Meja</city>
        <zip>B1704ETD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Privado de Rosario</name>
      <address>
        <city>Rosario</city>
        <zip>S2000GAP</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Consultorio del Dr. Aiub</name>
      <address>
        <city>San Isidro</city>
        <zip>1642</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanatorio San Lucas</name>
      <address>
        <city>San Isidro</city>
        <zip>B1642DJG</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unidad Coronaria San Geronimo S.R.L.</name>
      <address>
        <city>Santa Fe</city>
        <zip>3000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Juncal</name>
      <address>
        <city>Temperley</city>
        <zip>1834</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanatorio 9 de Julio S.A.</name>
      <address>
        <city>Tucuman</city>
        <zip>4000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Privado de Cardiologa</name>
      <address>
        <city>Tucumn</city>
        <zip>T4000NIL</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CEMEDIC - Centro de Especialidades Medicas</name>
      <address>
        <city>Villa Luro</city>
        <zip>1407</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Vera Cruz</name>
      <address>
        <city>Belo Horizonte</city>
        <zip>30140-092</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Procardio Ltda</name>
      <address>
        <city>Blumenau</city>
        <zip>89010-500</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital do Coracao do Brasil</name>
      <address>
        <city>Brasilia</city>
        <zip>70390-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Cardiologia do Distrito Federal</name>
      <address>
        <city>Brasilia</city>
        <zip>70658-700</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Angelina Caron</name>
      <address>
        <city>Campina Grande do Sul</city>
        <zip>83430-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Especializado em Cardiol Loema Instituto de Pesq Clin</name>
      <address>
        <city>Campinas</city>
        <zip>13010-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HMCP - Hospital e Maternidade Celso Pierro - PUC-Campinas</name>
      <address>
        <city>Campinas</city>
        <zip>13060-904</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Nossa Senhora de Pompeia</name>
      <address>
        <city>Caxias do Sul</city>
        <zip>95084-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Irmandade da Santa Casa de Misericordia de Curitiba</name>
      <address>
        <city>Curitiba</city>
        <zip>80010-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barroso e Sebba Ltda</name>
      <address>
        <city>Goiania</city>
        <zip>74223-130</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CLINICOR-Clinica de Exames Cardiolog e Ecografias S S LTDA</name>
      <address>
        <city>Maceio</city>
        <zip>57051-500</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital So Vicente de Paulo</name>
      <address>
        <city>Passo Fundo</city>
        <zip>99010-080</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Clnicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <zip>90035-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacao Universitaria de Cardiologia - Inst de Cardiologia</name>
      <address>
        <city>Porto Alegre</city>
        <zip>90620-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pronto Socorro Cardiolgico de Pernambuco Prof. Luiz Tavares</name>
      <address>
        <city>Recife</city>
        <zip>50100-130</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Copa D'or</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>22031-011</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacao Pro-Coracao FUNDACOR</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>22240-004</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Cardiopulmonar da Bahia LTDA</name>
      <address>
        <city>Salvador</city>
        <zip>40170-130</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacao Bahiana de Cardiologia</name>
      <address>
        <city>Salvador</city>
        <zip>41810-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Ensino E Pesquisa Do Hospital Da Bahia</name>
      <address>
        <city>Salvador</city>
        <zip>41810-011</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Molestias Cardiovasculares - IMC</name>
      <address>
        <city>Sao Jose do Rio Preto</city>
        <zip>15015-210</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hcor - Hospital do Coracao</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04004-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Dante Pazzanese de Cardiologia</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04012-180</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Marcelina</name>
      <address>
        <city>Sao Paulo</city>
        <zip>08270-070</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Sao Paulo UNIFESP</name>
      <address>
        <city>Sao Paulo</city>
        <zip>4038-031</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H.S.J. Beneficncia Portuguesa - So Paulo</name>
      <address>
        <city>So Paulo</city>
        <zip>01323-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FGM - Clnica Paulista de Doenas Cardiovasculares</name>
      <address>
        <city>So Paulo</city>
        <zip>01327-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital das Clinicas da Faculdade de Medicina - FMUSP</name>
      <address>
        <city>So Paulo</city>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Molestias Cardiovasculares Tatui SP</name>
      <address>
        <city>Tatui</city>
        <zip>18270-170</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Casa de Votuporanga</name>
      <address>
        <city>Votuporanga</city>
        <zip>15500-003</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Alberta Hospital (University of Alberta)</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Road Clinical Research</name>
      <address>
        <city>Coquitlam</city>
        <state>British Columbia</state>
        <zip>V3K 3V9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kelowna General Hospital</name>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <zip>V1Y 1E4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Crestwood Med &amp; Dental Bldg</name>
      <address>
        <city>Richmond</city>
        <state>British Columbia</state>
        <zip>V7C 3V3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ocean West Research Clinic Inc.</name>
      <address>
        <city>Surrey</city>
        <state>British Columbia</state>
        <zip>V3S 2N6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Victoria Cardiac Arrhythmia Trials Inc.</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V8T 1Z4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Q &amp; T Research Chicoutimi Inc</name>
      <address>
        <city>Chicoutimi</city>
        <state>Migration Data</state>
        <zip>G7H 7Y8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CardioVasc HR Inc.</name>
      <address>
        <city>St-Jean-sur-Richel</city>
        <state>Migration Data</state>
        <zip>J3A 1C3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint John Regional Hospital</name>
      <address>
        <city>Saint John</city>
        <state>New Brunswick</state>
        <zip>E2L 4L2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Health (MUN)</name>
      <address>
        <city>St. John's</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1B 3V6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Antigonish Medical Associates Inc.</name>
      <address>
        <city>Antigonish</city>
        <state>Nova Scotia</state>
        <zip>B2G 2C7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>QEII Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 3A7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cambridge Cardiac Care Inc.</name>
      <address>
        <city>Cambridge</city>
        <state>Ontario</state>
        <zip>N1R 6V6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Lincoln Memorial Hospital</name>
      <address>
        <city>Grimsby</city>
        <state>Ontario</state>
        <zip>L3M 1P3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Winterberry Family Medicine</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8J 0B6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamilton Medical Research Group</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8M 1K7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8S 4T1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Victoria Hospital (LHSC)</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mississauga Clinical Research Centre</name>
      <address>
        <city>MIssissauga</city>
        <state>Ontario</state>
        <zip>L5B 2P7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SKDS Research Incorporated</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 5G8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>M Heffernan Medicine Professional Corp.</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <zip>L6K 3W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oshawa Clinic Cardiology Department, Oshawa, Courtice</name>
      <address>
        <city>Oshawa</city>
        <state>Ontario</state>
        <zip>L1H 1B9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ottawa Hospital - Civic Campus</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4E9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Ottawa Heart Institute Cardiology Research</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aviva Clinical Trial Group Inc.</name>
      <address>
        <city>Stoney Creek</city>
        <state>Ontario</state>
        <zip>L8J 2V8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SGH Medical Mall</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M1P 2T7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keele Medical Place</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M3M 3E5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique de Cardiologie de Levis</name>
      <address>
        <city>Levis</city>
        <state>Quebec</state>
        <zip>G6V 4Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHUM Hotel Dieu</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W 1T8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Recherche Clinique Sigma Inc.</name>
      <address>
        <city>Qubec</city>
        <state>Quebec</state>
        <zip>G1G 3Y8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IUCPQ (Laval University)</name>
      <address>
        <city>Sainte-Foy</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHUS Fleurimont</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baycole Research</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7L 2W1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clnico Fuerza Area de Chile</name>
      <address>
        <city>Santiago</city>
        <zip>7560171</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Estudios Clinicos Barros Luco</name>
      <address>
        <city>Santiago</city>
        <zip>8910131</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital y CRS El Pino</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CECMI Ltda</name>
      <address>
        <city>Temuco</city>
        <zip>4813299</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Tabancura</name>
      <address>
        <city>Vitacura</city>
        <zip>7650018</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CINVEC - Centro de Investigacion Clinica V Reg.,Vina del Mar</name>
      <address>
        <city>Via del Mar</city>
        <zip>2520997</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing AnZhen Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Institute and Fu Wai Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100037</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Shijingshan Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100043</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Tsinghua Changgung Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xiangya Hospital, Central South University</name>
      <address>
        <city>Changsha</city>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>2nd Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <zip>410011</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chinese Traditional Medicine Hospital of Sichuna Provinc</name>
      <address>
        <city>Chengdu</city>
        <zip>610000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center Hospital of Dalian</name>
      <address>
        <city>Dalian</city>
        <zip>116033</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foshan Hospital of Southern Medical University</name>
      <address>
        <city>Foshan</city>
        <zip>528000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fujian Provincal Hospital</name>
      <address>
        <city>Fuzhou</city>
        <zip>350001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guangdong Provincial People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Afiliated Hospital, Sun Yet-sen University</name>
      <address>
        <city>Guangzhou</city>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wu Jing Zong Dui Hospital of Guangdong Province</name>
      <address>
        <city>Guangzhou</city>
        <zip>510507</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Jinan University</name>
      <address>
        <city>Guangzhou</city>
        <zip>510630</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Hangzhou Normal University</name>
      <address>
        <city>Hangzhou</city>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hangzhou First People's Hospital</name>
      <address>
        <city>Hangzhou</city>
        <zip>310006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shandong Jiaotong Hospital</name>
      <address>
        <city>Jinan</city>
        <zip>250000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center Hospital of Jinan</name>
      <address>
        <city>Jinan</city>
        <zip>250013</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Qianfoshan Hospital affiliated to Shandong University</name>
      <address>
        <city>Jinan</city>
        <zip>250014</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shandong Provincial Hospital</name>
      <address>
        <city>Jinan</city>
        <zip>250021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jining No.1 people's hospital</name>
      <address>
        <city>Jining</city>
        <zip>272111</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital to Nanchang University</name>
      <address>
        <city>Nanchang</city>
        <zip>330006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zhongda Hospital Southeast University</name>
      <address>
        <city>Nanjing</city>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The affiliated hospital of medicalcollege qingdao university</name>
      <address>
        <city>Qingdao</city>
        <zip>266003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>QingDao Municipal Hospital</name>
      <address>
        <city>QingDao</city>
        <zip>266011</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Qingdao Fuwai Hospital</name>
      <address>
        <city>Qingdao</city>
        <zip>266034</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Qingdao Central Hospital</name>
      <address>
        <city>Qingdao</city>
        <zip>266042</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chinese People's Liberation Army 401 Hospital</name>
      <address>
        <city>Qingdao</city>
        <zip>266071</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huashan Hospital, Fudan University</name>
      <address>
        <city>Shanghai</city>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai Huadong Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital, Tongji University</name>
      <address>
        <city>Shanghai</city>
        <zip>200065</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai East Hospital, Tongji University China</name>
      <address>
        <city>Shanghai</city>
        <zip>200120</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Renji Hospital Shanghai Jiaotong Univesrity School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minhang District Central Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>201199</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Songjiang Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>201600</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jiading Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>201800</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shengjing Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <zip>110004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital of Shenyang Military Region</name>
      <address>
        <city>Shenyang</city>
        <zip>110015</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Liaoning Province</name>
      <address>
        <city>Shenyang</city>
        <zip>110016</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Forth People's Hospital of Shenzhen</name>
      <address>
        <city>Shenzhen</city>
        <zip>518033</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hebei Provincial Tumor Hospital</name>
      <address>
        <city>Shijiazhuang</city>
        <zip>050011</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SuZhou Kowloon Hospital</name>
      <address>
        <city>Suzhou</city>
        <zip>215021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Central Hospital of Tai'an</name>
      <address>
        <city>Tai'an</city>
        <zip>250001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanxi Cardiovascular Hospital</name>
      <address>
        <city>Taiyuan</city>
        <zip>030024</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wu Jing Yi Xue Yuan Fu Shu Yi Yuan</name>
      <address>
        <city>Tianjin</city>
        <zip>300162</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wuhan Asia Heart Hospital</name>
      <address>
        <city>Wuhan</city>
        <zip>430022</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hubei Province Zhongshan Hospital</name>
      <address>
        <city>Wuhan</city>
        <zip>430032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Xiamen University</name>
      <address>
        <city>Xiamen</city>
        <zip>361003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xiamen Cardiovascular Hospital Xiamen University</name>
      <address>
        <city>Xiamen</city>
        <zip>361004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xuzhou Central Hospital</name>
      <address>
        <city>Xuzhou</city>
        <zip>221009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Subei People's Hospital</name>
      <address>
        <city>Yangzhou</city>
        <zip>225001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>zhengzhou No.7 people's Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <zip>450006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zhengzhou Central Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <zip>450007</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zhengzhou People'S Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <zip>450012</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yankuang Group General Hospital</name>
      <address>
        <city>Zoucheng</city>
        <zip>273500</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Clara E.S.E.</name>
      <address>
        <city>Bogota DC</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacion Clinica Shaio</name>
      <address>
        <city>Bogota</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacion Hospital Infantil Universitario de San Jos</name>
      <address>
        <city>Bogot</city>
        <zip>111221</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Simedics Ips</name>
      <address>
        <city>Bogot</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Mdico Julin Coronel</name>
      <address>
        <city>Cali -Valle Del Cauca</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacion Valle de Lilly</name>
      <address>
        <city>Cali</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Diagnostico Cardilogico</name>
      <address>
        <city>Cartagena de Indias</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacion Cardiovascular de Colombia</name>
      <address>
        <city>Floridablanca</city>
        <zip>68004</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asociacion IPS Medicos Internistas de Caldas</name>
      <address>
        <city>Manizales</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ces Cardiologa</name>
      <address>
        <city>Medellin</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ciclam Sas</name>
      <address>
        <city>Medelln</city>
        <zip>5001000</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacion Cardiomet Centro de Investigaciones CEQUIN</name>
      <address>
        <city>Quindio</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Teodoro Maldonado Carbo</name>
      <address>
        <city>Guayaquil</city>
        <zip>190150</zip>
        <country>Ecuador</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unicormed SA</name>
      <address>
        <city>Guayaquil</city>
        <country>Ecuador</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital INTERVASCU</name>
      <address>
        <city>Quito</city>
        <zip>170122</zip>
        <country>Ecuador</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Hospital</name>
      <address>
        <city>Hong Kong</city>
        <zip>0</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <zip>0</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Hong Kong</city>
        <zip>999077</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asahi General Hospital</name>
      <address>
        <city>Chiba, Asahi</city>
        <zip>289-2511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seikeikai New Tokyo Heart Clinic</name>
      <address>
        <city>Chiba, Matsudo</city>
        <zip>271-0077</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saiseikai Matsuyama Hospital</name>
      <address>
        <city>Ehime, Matsuyama</city>
        <zip>791-8026</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fukuiken Saiseikai Hospital</name>
      <address>
        <city>Fukui, Fukui</city>
        <zip>918-8503</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Japanese Red Cross Fukuoka Hospital</name>
      <address>
        <city>Fukuoka, Fukuoka</city>
        <zip>815-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aso Co.,Ltd Iizuka Hospital</name>
      <address>
        <city>Fukuoka, Iizuka</city>
        <zip>820-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nakamura Cardiovascular Clinic</name>
      <address>
        <city>Fukuoka, Itoshima</city>
        <zip>819-1104</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fukuoka Tokushukai Medical Center</name>
      <address>
        <city>Fukuoka, Kasuga</city>
        <zip>816-0864</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shin Komonji Hospital</name>
      <address>
        <city>Fukuoka, Kitakyushu</city>
        <zip>800-0057</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fukuoka Shin Mizumaki Hospital</name>
      <address>
        <city>Fukuoka, Onga</city>
        <zip>807-0051</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Matsuda Cardiovascular Clinic</name>
      <address>
        <city>Hokkaido, Sapporo</city>
        <zip>003-0026</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kobe City Medical Center General Hospital</name>
      <address>
        <city>Hyogo, Kobe</city>
        <zip>650-0047</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Higashi Takarazuka Satoh Hospital</name>
      <address>
        <city>Hyogo, Takarazuka</city>
        <zip>665-0873</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Houju Memorial Hospital</name>
      <address>
        <city>Isikawa, Nomi</city>
        <zip>923-1226</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KKR Takamatsu Hospital</name>
      <address>
        <city>Kagawa , Takamatsu</city>
        <zip>760-0018</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kagawa Prefectural Shirotori Hospital</name>
      <address>
        <city>Kagawa, Higashikagawa</city>
        <zip>769-2788</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kokan Clinic</name>
      <address>
        <city>Kanagawa, Kawasaki</city>
        <zip>210-0852</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sekishinkai Kawasaki Saiwai Clinic</name>
      <address>
        <city>Kanagawa, Kawasaki</city>
        <zip>212-0016</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sagamihara Kyodo Hospital</name>
      <address>
        <city>Kanagawa, Sagamihara</city>
        <zip>252-5188</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Social Medical Corporation Chikamorikai Chikamori Hospital</name>
      <address>
        <city>Kochi, Kochi</city>
        <zip>780-8522</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nakayama Clinic of I.M. and Cardiology, Kochi, Cardiology</name>
      <address>
        <city>Kochi, Kochi</city>
        <zip>781-5106</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sugimurakai Medical Association Sugimura Hospital</name>
      <address>
        <city>Kumamoto, Kumamoto</city>
        <zip>860-0811</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Japan Community Health care Organization Kumamoto General Hospital</name>
      <address>
        <city>Kumamoto, Yatsushiro</city>
        <zip>866-8660</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uji-Tokushukai Medical Center</name>
      <address>
        <city>Kyoto, Uji</city>
        <zip>611-0041</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iida Municipal Hospital</name>
      <address>
        <city>Nagano, Iida</city>
        <zip>395-8502</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Suwa Red Cross Hospital</name>
      <address>
        <city>Nagano, Suwa</city>
        <zip>392-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tachikawa General Hospital</name>
      <address>
        <city>Niigata, Nagaoka</city>
        <zip>940-8621</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nozaki Tokushukai Hospital</name>
      <address>
        <city>Osaka, Daito</city>
        <zip>574-0074</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Teramoto Memorial Hospital</name>
      <address>
        <city>Osaka, Kawachinagano</city>
        <zip>586-0017</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Matsubara Tokushukai Hospital</name>
      <address>
        <city>Osaka, Matsubara</city>
        <zip>580-0032</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka Saiseikai Nakatsu Hospital</name>
      <address>
        <city>Osaka, Osaka</city>
        <zip>530-0012</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kitano Hospital</name>
      <address>
        <city>Osaka, Osaka</city>
        <zip>530-8480</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka Kaisei Hospital</name>
      <address>
        <city>Osaka, Osaka</city>
        <zip>532-0003</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ishinkai General Clinics</name>
      <address>
        <city>Osaka, Yao</city>
        <zip>581-0036</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical corporation Chisei-kai Watanabe clinic</name>
      <address>
        <city>Saitama, Okegawa</city>
        <zip>363-0022</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SAINO Clinic</name>
      <address>
        <city>Saitama, Tokorozawa</city>
        <zip>359-1141</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kusatsu Heart Center</name>
      <address>
        <city>Shiga, Kusatsu</city>
        <zip>525-0014</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shizuoka Tokushukai Hospital</name>
      <address>
        <city>Shizuoka, Shizuoka</city>
        <zip>421-0193</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Institute for Adult Deseases, Asahi Life Foundation</name>
      <address>
        <city>Tokyo, Chuo-ku</city>
        <zip>103-0002</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minamino Heart Clinic</name>
      <address>
        <city>Tokyo, Hachioji</city>
        <zip>192-0918</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shimizu Clinic</name>
      <address>
        <city>Tokyo, Kodaira</city>
        <zip>187-0003</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Cardiovascular Institute Hospital</name>
      <address>
        <city>Tokyo, Minato-ku</city>
        <zip>106-0031</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>YOGA Urban Clinic</name>
      <address>
        <city>Tokyo, Setagaya</city>
        <zip>158-0097</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Toyama Hospital</name>
      <address>
        <city>Toyama, Toyama</city>
        <zip>930-0194</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sejong General Hospital</name>
      <address>
        <city>Bucheon</city>
        <zip>14754</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dong-A University Hospital</name>
      <address>
        <city>Busan</city>
        <zip>49201</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kosin University Gospel Hospital</name>
      <address>
        <city>Busan</city>
        <zip>602-702</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pusan National Univ. Hosp</name>
      <address>
        <city>Busan</city>
        <zip>602-739</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inje University Haeundae Paik Hospital</name>
      <address>
        <city>Busan</city>
        <zip>612-896</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inje University Busan Paik Hospital</name>
      <address>
        <city>Busan</city>
        <zip>614-735</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keimyung University Dongsan Medical Center</name>
      <address>
        <city>Daegu</city>
        <zip>41931</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyungpook National Univ. Hosp</name>
      <address>
        <city>Daegu</city>
        <zip>700-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Daegu Fatima Hospital</name>
      <address>
        <city>Daegu</city>
        <zip>701-724</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yeungnam University Medical Center</name>
      <address>
        <city>Daegu</city>
        <zip>705-703</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea, Daejeon St.Mary's Hospital</name>
      <address>
        <city>Daejeon</city>
        <zip>301-723</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eulji University Hospital</name>
      <address>
        <city>Daejeon</city>
        <zip>302-799</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chonnam National University Hospital</name>
      <address>
        <city>Gwangju</city>
        <zip>501-757</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wonkwang University Hospital</name>
      <address>
        <city>Iksan</city>
        <zip>54538</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jeju National University Hospital</name>
      <address>
        <city>Jeju</city>
        <zip>63241</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chonbuk National University Hospital</name>
      <address>
        <city>Jeonju</city>
        <zip>54907</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gyeongsang National University Hospital</name>
      <address>
        <city>Jinju</city>
        <zip>52727</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyung Hee University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>02447</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>02841</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kangdong Sacred Heart Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>05355</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VHS Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>05368</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea, Seoul St.Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea, Eunpyeong St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>130-709</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ajou University Hospital</name>
      <address>
        <city>Suwon</city>
        <zip>16499</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ulsan University Hospital</name>
      <address>
        <city>Ulsan</city>
        <zip>682-714</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pusan National University Yangsan Hospital</name>
      <address>
        <city>Yangsan</city>
        <zip>626-770</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St.Charles Hospital</name>
      <address>
        <city>Baabda</city>
        <zip>50 Baabda</zip>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Makassed General Hospital</name>
      <address>
        <city>Beirut</city>
        <zip>11-6301</zip>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Georges Hospital</name>
      <address>
        <city>Beirut</city>
        <zip>166 378</zip>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hotel Dieu de France Hospital</name>
      <address>
        <city>Beirut</city>
        <zip>166830</zip>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rafik Hariri University Hospital</name>
      <address>
        <city>Beirut</city>
        <zip>5244</zip>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Al Rassoul Hospital, Beirut Cardiac Institute</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>American University of Beirut Medical Center</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bellvue Medical Center, Beirut</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Notre Dame de Secours Hospital</name>
      <address>
        <city>Byblos</city>
        <zip>3</zip>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hammoud Hospital University Medical Center</name>
      <address>
        <city>Saida</city>
        <zip>652</zip>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General de Acapulco</name>
      <address>
        <city>Acapulco De Jurez, Guerrero</city>
        <zip>39570</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Cardiologica Aguascalientes</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christius Muguerza Hospital del Parque</name>
      <address>
        <city>Chihuahua</city>
        <zip>31020</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Especializado de Investigacin Medical Group Culiacan</name>
      <address>
        <city>Culiacan</city>
        <zip>80200</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro para el Desarrollo de la Medicina y de Asist Med Espe</name>
      <address>
        <city>Culiacan</city>
        <zip>80230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Cardiologia Ignacio Chavez</name>
      <address>
        <city>Distrito Federal</city>
        <zip>14080</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unidad Coronariana del Hospital General de Durango</name>
      <address>
        <city>Durango</city>
        <zip>34000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Investigacin Especializada de Occidente S.C.</name>
      <address>
        <city>Guadalajara</city>
        <zip>44160</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clnica de Estudios Mdicos S.C.</name>
      <address>
        <city>Guadalajara</city>
        <zip>44600</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ICLE SC</name>
      <address>
        <city>Guadalajara</city>
        <zip>44600</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practice</name>
      <address>
        <city>Guadalajara</city>
        <zip>44670</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paracelsus S. A. de C.V.</name>
      <address>
        <city>Mexico</city>
        <zip>03800</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Miravalle</name>
      <address>
        <city>Monterrey, Nuevo Leon</city>
        <zip>64000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Metropolitano &quot;Dr Bernardo Sepulveda&quot;</name>
      <address>
        <city>Monterrey</city>
        <zip>66480</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unidad de Investigacion Clinica en Medicina, S.C.</name>
      <address>
        <city>Monterrrey</city>
        <zip>64718</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Consultorio Privado J Arturo Maldonado Villalon</name>
      <address>
        <city>Morelia, Michoacan</city>
        <zip>58260</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Medico de las Americas</name>
      <address>
        <city>Mrida, Yucatn</city>
        <zip>97000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Medical Research S.C</name>
      <address>
        <city>Orizaba</city>
        <zip>94300</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Corazn de Quertaro</name>
      <address>
        <city>Quertaro</city>
        <zip>76000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardioarritmias e Investigacin S.C</name>
      <address>
        <city>San Luis Potosi</city>
        <zip>78200</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Plaza Medical</name>
      <address>
        <city>Tijuana</city>
        <zip>22320</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Servicios Diagnosticos en Medicina SC</name>
      <address>
        <city>Toluca, Estado De Mexico</city>
        <zip>52140</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>iBiomed</name>
      <address>
        <city>Zapopan</city>
        <zip>45030</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Medico Monte Carmelo</name>
      <address>
        <city>Arequipa</city>
        <zip>054</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Nacional Daniel Alcides Carrion</name>
      <address>
        <city>Bellavista</city>
        <zip>Callao 2</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EsSalud - Hospital Nacional IV Alberto Sabogal Sologuren</name>
      <address>
        <city>Callao</city>
        <zip>C2</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Nacional Guillermo Almenara Irigoyen</name>
      <address>
        <city>La Victoria</city>
        <zip>Lima-13</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Nacional Edgardo Rebaglini Martins</name>
      <address>
        <city>Lima</city>
        <zip>Lima-11</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica San Pablo</name>
      <address>
        <city>Lima</city>
        <zip>Lima-33</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Investigacin en Diabetes, Obesidad y Nutricin</name>
      <address>
        <city>Lince</city>
        <zip>Lima-14</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Internacional</name>
      <address>
        <city>San Borja</city>
        <zip>LIMA 41</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Vesalio</name>
      <address>
        <city>San Borja</city>
        <zip>lima-41</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica El Golf</name>
      <address>
        <city>San Isidro</city>
        <zip>Lima-27</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Medica Cayetano Heredia</name>
      <address>
        <city>San Martin de Porres</city>
        <zip>Lima-31</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Altaiskyi Reg.Cardiologic Dispensary,Cardiology Dept,Barnaul</name>
      <address>
        <city>Barnaul</city>
        <zip>656055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chelyabinsk State Med.Acad, Dept. of Clinical Pharmacology</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454092</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chita State Med.Acad, Consultative-Diagnostic-Polyclinic</name>
      <address>
        <city>Chita</city>
        <zip>672090</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OJSC Municipal Instit.Dzerjinskiy City Hospital</name>
      <address>
        <city>Dzerjinskiy</city>
        <zip>140 091</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GBUZ SO Ural Institute of Cardiology, Ekaterinburg</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620 144</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Road Clin.Hosp.Irkutsk-Russian Railways,Cardio.&amp;Therapy Dept</name>
      <address>
        <city>Irkutsk</city>
        <zip>664005</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Clin.Hosp.#9,Intern.Diseases&amp;Fam.Practice Dept, Izhevsk</name>
      <address>
        <city>Izhevsk</city>
        <zip>426063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Res.Inst.-Compl.Iss.Cardi.Dis.</name>
      <address>
        <city>Kemerovo</city>
        <zip>650002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Municipal Instit. City Hosp. No.2, Policlinic Dept,Krasnodar</name>
      <address>
        <city>Krasnodar</city>
        <zip>350 012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GOU VPO MUZ City Clinical Hospital No. 20, Krasnoyarsk</name>
      <address>
        <city>Krasnoyarsk</city>
        <zip>660014</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Moscow 1st State Med.Univ.n.a.I.M.Sechenov</name>
      <address>
        <city>Moscow</city>
        <zip>119992</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Center n.a.A.N.Bakulev,Clin.-Diagnostic Dept,Moscow</name>
      <address>
        <city>Moscow</city>
        <zip>121552</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Russian Cardiology Research and Production Complex, Moscow</name>
      <address>
        <city>Moscow</city>
        <zip>121552</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reg.Clin.Cardiological Dispen,Arrhythmology Dept,Novosibirsk</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630047</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Omsk State Medical Acad.,Internal Diseases&amp;Fam.Practice Dept</name>
      <address>
        <city>Omsk</city>
        <zip>644043</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orenburg State Medical Academy of MoH, Therapy Department</name>
      <address>
        <city>Orenburg</city>
        <zip>460 000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instit.Healthcare,MedicalSanitary Unit 9,n.a.M.A.Tverie,Perm</name>
      <address>
        <city>Perm</city>
        <zip>614990</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rostov Regional Clinical Hospital</name>
      <address>
        <city>Rostov-on-Don</city>
        <zip>344015</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ryazan Reg.Clin.Hosp.Internal Diseases&amp;Policlin.Therapy Dept</name>
      <address>
        <city>Ryazan</city>
        <zip>390039</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samara Regional Clinical Cardiology Clinic, Day Hosp. Dept.</name>
      <address>
        <city>Samara</city>
        <zip>443070</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samara State Medical University, Chair of Faculty Therapy</name>
      <address>
        <city>Samara</city>
        <zip>443099</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Municipal Instit.Healthcare,City Policlinic #6,Therapy Dept.</name>
      <address>
        <city>Saratov</city>
        <zip>410015</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fed.Centre of Heart, Blood &amp; Endocrinology n.a. V.A. Almazov</name>
      <address>
        <city>St. Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pokrovskaya City Hospital, St.Petersburg</name>
      <address>
        <city>St. Petersburg</city>
        <zip>199106</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Primorskiy Regional Clinical Hospital No. 1</name>
      <address>
        <city>Vladivostok</city>
        <zip>690091</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Fahad Military Hospital</name>
      <address>
        <city>Dammam</city>
        <zip>9862</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Fahad Hufuf Hospital</name>
      <address>
        <city>Hufuf</city>
        <zip>36441</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Khamis Military Hospital</name>
      <address>
        <city>Jeddah</city>
        <zip>21424</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Abdul Aziz University Hospital</name>
      <address>
        <city>Jeddah</city>
        <zip>22254</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince Salman Heart Center</name>
      <address>
        <city>Riyadh</city>
        <zip>11525</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Salman Hospital</name>
      <address>
        <city>Riyadh</city>
        <zip>11536</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tabuk Military Hospital</name>
      <address>
        <city>Tabuk</city>
        <zip>71411</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Faisal Hospital</name>
      <address>
        <city>Taif</city>
        <zip>21944</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>119074</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Heart Center</name>
      <address>
        <city>Singapore</city>
        <zip>169609</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novena Heart Centre</name>
      <address>
        <city>Singapore</city>
        <zip>307506</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Neuroscience Institute</name>
      <address>
        <city>Singapore</city>
        <zip>308433</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. N. Ranjith</name>
      <address>
        <city>Durban</city>
        <zip>4052</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr Mahesh Duki Research and Trial Site</name>
      <address>
        <city>Durban</city>
        <zip>4339</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LCS Clinical Research Unit</name>
      <address>
        <city>Johannesburg</city>
        <zip>2021</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helderberg Research Institute</name>
      <address>
        <city>Somerset West, Cape Town</city>
        <zip>7130</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Moodley and Dr. Sarvan</name>
      <address>
        <city>Tongaat</city>
        <zip>4400</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaohsiung Medical University Chung-Ho Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>80756</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaohsiung Chang Gung Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>83301</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taichung Veterans General Hospital</name>
      <address>
        <city>Taichung</city>
        <zip>407</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NCKUH</name>
      <address>
        <city>Tainan</city>
        <zip>704</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>10002</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mackay Memorial Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>10449</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cathay General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>106</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taipei Veterans General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>11217</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cheng Hsin General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>11220</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital(Linkou)</name>
      <address>
        <city>Taoyuan</city>
        <zip>330</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Al Ain Hospital</name>
      <address>
        <city>Abu Dhabi</city>
        <zip>1006</zip>
        <country>United Arab Emirates</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheikh Khalifa Medical City</name>
      <address>
        <city>Abu Dhabi</city>
        <zip>51900</zip>
        <country>United Arab Emirates</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dubai Hospital</name>
      <address>
        <city>Dubai</city>
        <zip>7272</zip>
        <country>United Arab Emirates</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Al Qassimi Hospital</name>
      <address>
        <city>Sharjah</city>
        <zip>PO BOX 2804</zip>
        <country>United Arab Emirates</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Clinicas y Urologia Tamanaco</name>
      <address>
        <city>San Roman Caracas</city>
        <zip>1060</zip>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>China</country>
    <country>Colombia</country>
    <country>Ecuador</country>
    <country>Hong Kong</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Lebanon</country>
    <country>Mexico</country>
    <country>Peru</country>
    <country>Russian Federation</country>
    <country>Saudi Arabia</country>
    <country>Singapore</country>
    <country>South Africa</country>
    <country>Taiwan</country>
    <country>United Arab Emirates</country>
    <country>United States</country>
    <country>Venezuela</country>
  </location_countries>
  <removed_countries>
    <country>Croatia</country>
    <country>Puerto Rico</country>
    <country>Turkey</country>
  </removed_countries>
  <link>
    <url>https://www.mystudywindow.com</url>
    <description>Related Info</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>October 28, 2011</study_first_submitted>
  <study_first_submitted_qc>November 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2011</study_first_posted>
  <results_first_submitted>December 21, 2020</results_first_submitted>
  <results_first_submitted_qc>March 3, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 29, 2021</results_first_posted>
  <last_update_submitted>March 3, 2021</last_update_submitted>
  <last_update_submitted_qc>March 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 9, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/01/NCT01468701/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 7, 2013</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/01/NCT01468701/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>GLORIA-AF was an international, multicentre, non-interventional study based on prospectively collected data for patients (pts) with newly diagnosed non-valvular atrial fibrillation (NVAF). In Ph II, pts baseline characteristics (BC), their antithrombotic treatment patterns and outcomes with 2 years of follow-up for dabigatran alone were collected prospectively. Ph III collected prospective data on pts BC, their treatments and outcomes with 3 years of follow-up for all pts in real-world setting.</recruitment_details>
      <pre_assignment_details>All patients were screened for eligibility prior to participation in the study. Patients attended a participating site which ensured that they (the patients) strictly met all inclusion and none of the exclusion criteria.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Dabigatran Etexilate - Baseline (Phase II)</title>
          <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P2">
          <title>Vitamin K Antagonist (VKA) - Baseline (Phase II)</title>
          <description>Patients who were prescribed Vitamin K Antagonist (VKA) at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P3">
          <title>Rivaroxaban - Baseline (Phase II)</title>
          <description>Patients who were prescribed Rivaroxaban at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P4">
          <title>Apixaban - Baseline (Phase II)</title>
          <description>Patients who were prescribed Apixaban at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P5">
          <title>Acetylsalicylic Acid (ASA) - Baseline (Phase II)</title>
          <description>Patients who were prescribed Acetylsalicylic acid (ASA) at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P6">
          <title>Antiplts Other Than ASA - Baseline (Phase II)</title>
          <description>Patients who were prescribed Antiplts other than Acetylsalicylic acid (ASA) at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P7">
          <title>No Treatment - Baseline (Phase II)</title>
          <description>Patients who were not prescribed any antithrombotic treatments at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P8">
          <title>Combinations With Oral Anticoagulants - Baseline (Phase II)</title>
          <description>Patients who were prescribed combinations with oral anticoagulants treatments at baseline of Phase III were included in this group. Patients in this group were not included in the safety analysis as no specific treatment can be defined.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P9">
          <title>Dabigatran Etexilate - Baseline (Phase III)</title>
          <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P10">
          <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
          <description>Patients who were prescribed Vitamin K Antagonist (VKA) at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P11">
          <title>Rivaroxaban - Baseline (Phase III)</title>
          <description>Patients who were prescribed Rivaroxaban at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P12">
          <title>Apixaban - Baseline (Phase III)</title>
          <description>Patients who were prescribed Apixaban at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P13">
          <title>Edoxaban - Baseline (Phase III)</title>
          <description>Patients who were prescribed Edoxaban at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P14">
          <title>Acetylsalicylic Acid (ASA) - Baseline (Phase III)</title>
          <description>Patients who were prescribed Acetylsalicylic acid (ASA) at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P15">
          <title>Antiplts Other Than ASA - Baseline (Phase III)</title>
          <description>Patients who were prescribed Antiplatelets other than ASA at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may be used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P16">
          <title>No Treatment - Baseline (Phase III)</title>
          <description>Patients who were not prescribed any antithrombotic treatments at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="P17">
          <title>Combinations With Oral Anticoagulants - Baseline (Phase III)</title>
          <description>Patients who were prescribed combinations with oral anticoagulants treatments at baseline of Phase III were included in this group. Patients in this group were not included in the safety analysis as no specific treatment can be defined.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4964"/>
                <participants group_id="P2" count="5103"/>
                <participants group_id="P3" count="1784"/>
                <participants group_id="P4" count="715"/>
                <participants group_id="P5" count="1736"/>
                <participants group_id="P6" count="128"/>
                <participants group_id="P7" count="1209"/>
                <participants group_id="P8" count="5"/>
                <participants group_id="P9" count="3879"/>
                <participants group_id="P10" count="4962"/>
                <participants group_id="P11" count="4054"/>
                <participants group_id="P12" count="4538"/>
                <participants group_id="P13" count="333"/>
                <participants group_id="P14" count="2182"/>
                <participants group_id="P15" count="214"/>
                <participants group_id="P16" count="1418"/>
                <participants group_id="P17" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>All Eligible Patient</title>
              <participants_list>
                <participants group_id="P1" count="4873"/>
                <participants group_id="P2" count="4963"/>
                <participants group_id="P3" count="1755"/>
                <participants group_id="P4" count="703"/>
                <participants group_id="P5" count="1714"/>
                <participants group_id="P6" count="126"/>
                <participants group_id="P7" count="1170"/>
                <participants group_id="P8" count="4"/>
                <participants group_id="P9" count="3839"/>
                <participants group_id="P10" count="4836"/>
                <participants group_id="P11" count="4015"/>
                <participants group_id="P12" count="4505"/>
                <participants group_id="P13" count="332"/>
                <participants group_id="P14" count="2163"/>
                <participants group_id="P15" count="213"/>
                <participants group_id="P16" count="1386"/>
                <participants group_id="P17" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3965"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="3219"/>
                <participants group_id="P10" count="3780"/>
                <participants group_id="P11" count="3256"/>
                <participants group_id="P12" count="3672"/>
                <participants group_id="P13" count="284"/>
                <participants group_id="P14" count="1712"/>
                <participants group_id="P15" count="151"/>
                <participants group_id="P16" count="1056"/>
                <participants group_id="P17" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="999"/>
                <participants group_id="P2" count="5103"/>
                <participants group_id="P3" count="1784"/>
                <participants group_id="P4" count="715"/>
                <participants group_id="P5" count="1736"/>
                <participants group_id="P6" count="128"/>
                <participants group_id="P7" count="1209"/>
                <participants group_id="P8" count="5"/>
                <participants group_id="P9" count="660"/>
                <participants group_id="P10" count="1182"/>
                <participants group_id="P11" count="798"/>
                <participants group_id="P12" count="866"/>
                <participants group_id="P13" count="49"/>
                <participants group_id="P14" count="470"/>
                <participants group_id="P15" count="63"/>
                <participants group_id="P16" count="362"/>
                <participants group_id="P17" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Not eligible</title>
              <participants_list>
                <participants group_id="P1" count="91"/>
                <participants group_id="P2" count="140"/>
                <participants group_id="P3" count="29"/>
                <participants group_id="P4" count="12"/>
                <participants group_id="P5" count="22"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="39"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="40"/>
                <participants group_id="P10" count="126"/>
                <participants group_id="P11" count="39"/>
                <participants group_id="P12" count="33"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="19"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="32"/>
                <participants group_id="P17" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="306"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="215"/>
                <participants group_id="P10" count="309"/>
                <participants group_id="P11" count="224"/>
                <participants group_id="P12" count="212"/>
                <participants group_id="P13" count="11"/>
                <participants group_id="P14" count="164"/>
                <participants group_id="P15" count="17"/>
                <participants group_id="P16" count="127"/>
                <participants group_id="P17" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="165"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="83"/>
                <participants group_id="P10" count="88"/>
                <participants group_id="P11" count="100"/>
                <participants group_id="P12" count="114"/>
                <participants group_id="P13" count="9"/>
                <participants group_id="P14" count="47"/>
                <participants group_id="P15" count="6"/>
                <participants group_id="P16" count="31"/>
                <participants group_id="P17" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other reasons than listed</title>
              <participants_list>
                <participants group_id="P1" count="437"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="318"/>
                <participants group_id="P10" count="658"/>
                <participants group_id="P11" count="433"/>
                <participants group_id="P12" count="504"/>
                <participants group_id="P13" count="28"/>
                <participants group_id="P14" count="239"/>
                <participants group_id="P15" count="39"/>
                <participants group_id="P16" count="172"/>
                <participants group_id="P17" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No end of study case report form</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="4"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="3"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Not being followed up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4963"/>
                <participants group_id="P3" count="1755"/>
                <participants group_id="P4" count="703"/>
                <participants group_id="P5" count="1714"/>
                <participants group_id="P6" count="126"/>
                <participants group_id="P7" count="1170"/>
                <participants group_id="P8" count="4"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
      <group_list>
        <group group_id="B1">
          <title>Dabigatran Etexilate - Baseline (Phase II)</title>
          <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B2">
          <title>Vitamin K Antagonist (VKA) - Baseline (Phase II)</title>
          <description>Patients who were prescribed Vitamin K Antagonist (VKA) at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B3">
          <title>Rivaroxaban - Baseline (Phase II)</title>
          <description>Patients who were prescribed Rivaroxaban at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B4">
          <title>Apixaban - Baseline (Phase II)</title>
          <description>Patients who were prescribed Apixaban at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B5">
          <title>Acetylsalicylic Acid (ASA) - Baseline (Phase II)</title>
          <description>Patients who were prescribed Acetylsalicylic acid (ASA) at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B6">
          <title>Antiplts Other Than ASA - Baseline (Phase II)</title>
          <description>Patients who were prescribed Antiplts other than Acetylsalicylic acid (ASA) at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B7">
          <title>No Treatment - Baseline (Phase II)</title>
          <description>Patients who were not prescribed any antithrombotic treatments at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B8">
          <title>Combinations With Oral Anticoagulants - Baseline (Phase II)</title>
          <description>Patients who were prescribed combinations with oral anticoagulants treatments at baseline of Phase II were included in this group. Patients in this group were not included in the safety analysis as no specific treatment can be defined.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B9">
          <title>Dabigatran Etexilate - Baseline (Phase III)</title>
          <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B10">
          <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
          <description>Patients who were prescribed Vitamin K Antagonist (VKA) at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B11">
          <title>Rivaroxaban - Baseline (Phase III)</title>
          <description>Patients who were prescribed Rivaroxaban at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B12">
          <title>Apixaban - Baseline (Phase III)</title>
          <description>Patients who were prescribed Apixaban at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B13">
          <title>Edoxaban - Baseline (Phase III)</title>
          <description>Patients who were prescribed Edoxaban at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B14">
          <title>Acetylsalicylic Acid (ASA) - Baseline (Phase III)</title>
          <description>Patients who were prescribed Acetylsalicylic acid (ASA) at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B15">
          <title>Antiplts Other Than ASA - Baseline (Phase III)</title>
          <description>Patients who were prescribed Antiplatelets other than ASA at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may be used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B16">
          <title>No Treatment - Baseline (Phase III)</title>
          <description>Patients who were not prescribed any antithrombotic treatments at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B17">
          <title>Combinations With Oral Anticoagulants - Baseline (Phase III)</title>
          <description>Patients who were prescribed combinations with oral anticoagulants treatments at baseline of Phase III were included in this group. Patients in this group were not included in the safety analysis as no specific treatment can be defined.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="B18">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4873"/>
            <count group_id="B2" value="4963"/>
            <count group_id="B3" value="1755"/>
            <count group_id="B4" value="703"/>
            <count group_id="B5" value="1714"/>
            <count group_id="B6" value="126"/>
            <count group_id="B7" value="1170"/>
            <count group_id="B8" value="4"/>
            <count group_id="B9" value="3839"/>
            <count group_id="B10" value="4836"/>
            <count group_id="B11" value="4015"/>
            <count group_id="B12" value="4505"/>
            <count group_id="B13" value="332"/>
            <count group_id="B14" value="2163"/>
            <count group_id="B15" value="213"/>
            <count group_id="B16" value="1386"/>
            <count group_id="B17" value="11"/>
            <count group_id="B18" value="36608"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70.2" spread="10.4"/>
                    <measurement group_id="B2" value="71.4" spread="10.6"/>
                    <measurement group_id="B3" value="71.5" spread="10.6"/>
                    <measurement group_id="B4" value="73.8" spread="10.0"/>
                    <measurement group_id="B5" value="67.7" spread="12.4"/>
                    <measurement group_id="B6" value="73.5" spread="10.7"/>
                    <measurement group_id="B7" value="68.3" spread="12.5"/>
                    <measurement group_id="B8" value="76.0" spread="8.3"/>
                    <measurement group_id="B9" value="70.1" spread="10.2"/>
                    <measurement group_id="B10" value="71.2" spread="10.3"/>
                    <measurement group_id="B11" value="70.3" spread="10.2"/>
                    <measurement group_id="B12" value="72.4" spread="10.1"/>
                    <measurement group_id="B13" value="72.3" spread="9.4"/>
                    <measurement group_id="B14" value="68.0" spread="11.8"/>
                    <measurement group_id="B15" value="73.1" spread="10.8"/>
                    <measurement group_id="B16" value="67.6" spread="12.2"/>
                    <measurement group_id="B17" value="70.2" spread="12.1"/>
                    <measurement group_id="B18" value="70.5" spread="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2162"/>
                    <measurement group_id="B2" value="2304"/>
                    <measurement group_id="B3" value="773"/>
                    <measurement group_id="B4" value="338"/>
                    <measurement group_id="B5" value="778"/>
                    <measurement group_id="B6" value="58"/>
                    <measurement group_id="B7" value="553"/>
                    <measurement group_id="B8" value="2"/>
                    <measurement group_id="B9" value="1718"/>
                    <measurement group_id="B10" value="2152"/>
                    <measurement group_id="B11" value="1766"/>
                    <measurement group_id="B12" value="2104"/>
                    <measurement group_id="B13" value="139"/>
                    <measurement group_id="B14" value="931"/>
                    <measurement group_id="B15" value="92"/>
                    <measurement group_id="B16" value="660"/>
                    <measurement group_id="B17" value="6"/>
                    <measurement group_id="B18" value="16536"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2711"/>
                    <measurement group_id="B2" value="2659"/>
                    <measurement group_id="B3" value="982"/>
                    <measurement group_id="B4" value="365"/>
                    <measurement group_id="B5" value="936"/>
                    <measurement group_id="B6" value="68"/>
                    <measurement group_id="B7" value="617"/>
                    <measurement group_id="B8" value="2"/>
                    <measurement group_id="B9" value="2121"/>
                    <measurement group_id="B10" value="2684"/>
                    <measurement group_id="B11" value="2249"/>
                    <measurement group_id="B12" value="2401"/>
                    <measurement group_id="B13" value="193"/>
                    <measurement group_id="B14" value="1232"/>
                    <measurement group_id="B15" value="121"/>
                    <measurement group_id="B16" value="726"/>
                    <measurement group_id="B17" value="5"/>
                    <measurement group_id="B18" value="20072"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="27"/>
                    <measurement group_id="B10" value="32"/>
                    <measurement group_id="B11" value="32"/>
                    <measurement group_id="B12" value="21"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="7"/>
                    <measurement group_id="B15" value="2"/>
                    <measurement group_id="B16" value="3"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="170"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="423"/>
                    <measurement group_id="B2" value="797"/>
                    <measurement group_id="B3" value="111"/>
                    <measurement group_id="B4" value="93"/>
                    <measurement group_id="B5" value="694"/>
                    <measurement group_id="B6" value="43"/>
                    <measurement group_id="B7" value="603"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="841"/>
                    <measurement group_id="B10" value="760"/>
                    <measurement group_id="B11" value="381"/>
                    <measurement group_id="B12" value="413"/>
                    <measurement group_id="B13" value="125"/>
                    <measurement group_id="B14" value="916"/>
                    <measurement group_id="B15" value="95"/>
                    <measurement group_id="B16" value="593"/>
                    <measurement group_id="B17" value="8"/>
                    <measurement group_id="B18" value="6896"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black/African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="86"/>
                    <measurement group_id="B3" value="42"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="44"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="23"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="47"/>
                    <measurement group_id="B10" value="85"/>
                    <measurement group_id="B11" value="72"/>
                    <measurement group_id="B12" value="118"/>
                    <measurement group_id="B13" value="2"/>
                    <measurement group_id="B14" value="49"/>
                    <measurement group_id="B15" value="2"/>
                    <measurement group_id="B16" value="23"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="647"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian/Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="2"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3372"/>
                    <measurement group_id="B2" value="3590"/>
                    <measurement group_id="B3" value="1375"/>
                    <measurement group_id="B4" value="538"/>
                    <measurement group_id="B5" value="863"/>
                    <measurement group_id="B6" value="70"/>
                    <measurement group_id="B7" value="497"/>
                    <measurement group_id="B8" value="4"/>
                    <measurement group_id="B9" value="2484"/>
                    <measurement group_id="B10" value="3611"/>
                    <measurement group_id="B11" value="3126"/>
                    <measurement group_id="B12" value="3528"/>
                    <measurement group_id="B13" value="203"/>
                    <measurement group_id="B14" value="1057"/>
                    <measurement group_id="B15" value="104"/>
                    <measurement group_id="B16" value="708"/>
                    <measurement group_id="B17" value="2"/>
                    <measurement group_id="B18" value="25132"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="447"/>
                    <measurement group_id="B2" value="262"/>
                    <measurement group_id="B3" value="69"/>
                    <measurement group_id="B4" value="24"/>
                    <measurement group_id="B5" value="82"/>
                    <measurement group_id="B6" value="10"/>
                    <measurement group_id="B7" value="21"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="181"/>
                    <measurement group_id="B10" value="144"/>
                    <measurement group_id="B11" value="144"/>
                    <measurement group_id="B12" value="79"/>
                    <measurement group_id="B13" value="2"/>
                    <measurement group_id="B14" value="57"/>
                    <measurement group_id="B15" value="7"/>
                    <measurement group_id="B16" value="32"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="1561"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Missing</title>
                  <measurement_list>
                    <measurement group_id="B1" value="571"/>
                    <measurement group_id="B2" value="211"/>
                    <measurement group_id="B3" value="151"/>
                    <measurement group_id="B4" value="34"/>
                    <measurement group_id="B5" value="26"/>
                    <measurement group_id="B6" value="3"/>
                    <measurement group_id="B7" value="24"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="259"/>
                    <measurement group_id="B10" value="204"/>
                    <measurement group_id="B11" value="260"/>
                    <measurement group_id="B12" value="345"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="75"/>
                    <measurement group_id="B15" value="3"/>
                    <measurement group_id="B16" value="27"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="2193"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Composite Outcome (Stroke, Systemic Embolism, Myocardial Infarction, Life-threatening Bleeding Events and Vascular Death) - Phase II</title>
        <description>Incidence rate of composite outcome which includes events of Stroke, systemic embolism, myocardial infarction, life-threatening bleeding events and vascular death on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only. In case of multiple events for a patient, the first event was considered.</description>
        <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
        <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase II)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Composite Outcome (Stroke, Systemic Embolism, Myocardial Infarction, Life-threatening Bleeding Events and Vascular Death) - Phase II</title>
          <description>Incidence rate of composite outcome which includes events of Stroke, systemic embolism, myocardial infarction, life-threatening bleeding events and vascular death on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only. In case of multiple events for a patient, the first event was considered.</description>
          <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4859"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.06" lower_limit="1.74" upper_limit="2.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Composite Outcome (Stroke, Systemic Embolism, Myocardial Infarction, Life-threatening Bleeding Events and Vascular Death) - Phase III</title>
        <description>Incidence rate of composite outcome which includes events of Stroke, systemic embolism, myocardial infarction, life-threatening bleeding events and vascular death on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. In case of multiple events for a patient, the first event was considered. Unknown cause of death was imputed by multiple imputation. Counts were based on the average of the 20 restricted data sets. The average of the 20 incidence rates from the 20 imputed datasets were used to obtain the point estimate of the incidence rate that is reported here. The bootstrapping approach was used to obtain the 95% confidence interval of the incidence rate.</description>
        <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
        <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase III)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
          <group group_id="O2">
            <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
            <description>Patients who were prescribed at baseline of Phase III the Vitamin K Antagonist (VKA) were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Composite Outcome (Stroke, Systemic Embolism, Myocardial Infarction, Life-threatening Bleeding Events and Vascular Death) - Phase III</title>
          <description>Incidence rate of composite outcome which includes events of Stroke, systemic embolism, myocardial infarction, life-threatening bleeding events and vascular death on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. In case of multiple events for a patient, the first event was considered. Unknown cause of death was imputed by multiple imputation. Counts were based on the average of the 20 restricted data sets. The average of the 20 incidence rates from the 20 imputed datasets were used to obtain the point estimate of the incidence rate that is reported here. The bootstrapping approach was used to obtain the 95% confidence interval of the incidence rate.</description>
          <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3611"/>
                <count group_id="O2" value="4413"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.21" lower_limit="1.88" upper_limit="2.57"/>
                    <measurement group_id="O2" value="3.23" lower_limit="2.83" upper_limit="3.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A multivariable Cox regression model was performed including variables of treatment, age, gender, prior bleed, previous stroke/transient ischaemic attack/systemic embolism, previous myocardial infarction, abnormal kidney function and concomitant antiplatelets use.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.74</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.60</ci_lower_limit>
            <ci_upper_limit>0.90</ci_upper_limit>
            <estimate_desc>Hazard ratio of dabigatran versus vitamin K antagonist (vitamin K antagonist as reference).</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Vascular Composite Outcome (Stroke, Systemic Embolism, Myocardial Infarction and Vascular Death) - Phase II</title>
        <description>Incidence rate of vascular composite outcome including events of stroke, systemic embolism, myocardial infarction and vascular death on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only. In case of multiple events for a patient, the first event was considered.</description>
        <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
        <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase II)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Vascular Composite Outcome (Stroke, Systemic Embolism, Myocardial Infarction and Vascular Death) - Phase II</title>
          <description>Incidence rate of vascular composite outcome including events of stroke, systemic embolism, myocardial infarction and vascular death on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only. In case of multiple events for a patient, the first event was considered.</description>
          <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4859"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.74" lower_limit="1.45" upper_limit="2.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Vascular Composite Outcome (Stroke, Systemic Embolism, Myocardial Infarction and Vascular Death) - Phase III</title>
        <description>Incidence rate of vascular composite outcome including events of stroke, systemic embolism, myocardial infarction and vascular death on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. In case of multiple events for a patient, the first event was considered. Unknown death was imputed by multiple imputation. Counts were based on the average of the 20 restricted data sets. The average of the 20 incidence rates from the 20 imputed datasets were used to obtain the point estimate of the incidence rate that is reported here. The bootstrapping approach was used to obtain the 95% confidence interval of the incidence rate.</description>
        <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
        <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase III)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
          <group group_id="O2">
            <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
            <description>Patients who were prescribed at baseline of Phase III the Vitamin K Antagonist (VKA) were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Vascular Composite Outcome (Stroke, Systemic Embolism, Myocardial Infarction and Vascular Death) - Phase III</title>
          <description>Incidence rate of vascular composite outcome including events of stroke, systemic embolism, myocardial infarction and vascular death on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. In case of multiple events for a patient, the first event was considered. Unknown death was imputed by multiple imputation. Counts were based on the average of the 20 restricted data sets. The average of the 20 incidence rates from the 20 imputed datasets were used to obtain the point estimate of the incidence rate that is reported here. The bootstrapping approach was used to obtain the 95% confidence interval of the incidence rate.</description>
          <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3611"/>
                <count group_id="O2" value="4413"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.91" lower_limit="1.59" upper_limit="2.24"/>
                    <measurement group_id="O2" value="2.62" lower_limit="2.27" upper_limit="2.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A multivariable Cox regression model was performed including variables of treatment, age, gender, prior bleed, previous stroke/transient ischaemic attack/systemic embolism, previous myocardial infarction, abnormal kidney function and concomitant antiplatelets use.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.79</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.63</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
            <estimate_desc>Hazard ratio of dabigatran versus vitamin K antagonist (vitamin K antagonist as reference).</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Stroke or Systemic Embolism - Phase III</title>
        <description>Incidence rate of stroke or systemic embolism on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
        <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
        <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase III)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
          <group group_id="O2">
            <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
            <description>Patients who were prescribed at baseline of Phase III the Vitamin K Antagonist (VKA) were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Stroke or Systemic Embolism - Phase III</title>
          <description>Incidence rate of stroke or systemic embolism on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
          <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3611"/>
                <count group_id="O2" value="4413"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.80" lower_limit="0.61" upper_limit="1.01"/>
                    <measurement group_id="O2" value="1.00" lower_limit="0.80" upper_limit="1.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A multivariable Cox regression model was performed including variables of treatment, age, gender, prior bleed, previous stroke/transient ischaemic attack/systemic embolism, previous myocardial infarction, abnormal kidney function and concomitant antiplatelets use.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.79</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.57</ci_lower_limit>
            <ci_upper_limit>1.11</ci_upper_limit>
            <estimate_desc>Hazard ratio of dabigatran versus vitamin K antagonist (vitamin K antagonist as reference).</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Stroke - Phase II</title>
        <description>Incidence rate of stroke on all eligible patients excluding prescribed but not taken set for Dabigatran etexilate (DE) of phase II only is presented. Stroke is an acute onset of a focal neurological deficit of presumed vascular origin lasting for 24 hours or more or resulting in death. The stroke included ischemic or hemorrhagic or uncertain classification.</description>
        <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
        <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase II)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Stroke - Phase II</title>
          <description>Incidence rate of stroke on all eligible patients excluding prescribed but not taken set for Dabigatran etexilate (DE) of phase II only is presented. Stroke is an acute onset of a focal neurological deficit of presumed vascular origin lasting for 24 hours or more or resulting in death. The stroke included ischemic or hemorrhagic or uncertain classification.</description>
          <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4859"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.65" lower_limit="0.48" upper_limit="0.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Stroke - Phase III</title>
        <description>Incidence rate of stroke on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. Stroke is an acute onset of a focal neurological deficit of presumed vascular origin lasting for 24 hours or more or resulting in death. The stroke included ischemic or hemorrhagic or uncertain classification.</description>
        <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
        <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase III)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
          <group group_id="O2">
            <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
            <description>Patients who were prescribed at baseline of Phase III the Vitamin K Antagonist (VKA) were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Stroke - Phase III</title>
          <description>Incidence rate of stroke on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. Stroke is an acute onset of a focal neurological deficit of presumed vascular origin lasting for 24 hours or more or resulting in death. The stroke included ischemic or hemorrhagic or uncertain classification.</description>
          <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3611"/>
                <count group_id="O2" value="4413"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.77" lower_limit="0.58" upper_limit="0.97"/>
                    <measurement group_id="O2" value="0.96" lower_limit="0.76" upper_limit="1.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A multivariable Cox regression model was performed including variables of treatment, age, gender, prior bleed, previous stroke/transient ischaemic attack/systemic embolism, previous myocardial infarction, abnormal kidney function and concomitant antiplatelets use.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.81</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.57</ci_lower_limit>
            <ci_upper_limit>1.14</ci_upper_limit>
            <estimate_desc>Hazard ratio of dabigatran versus vitamin K antagonist (vitamin K antagonist as reference).</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Transient Ischaemic Attack (TIA) - Phase II</title>
        <description>Incidence rate of transient ischaemic attack (TIA) on on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
        <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
        <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase II)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Transient Ischaemic Attack (TIA) - Phase II</title>
          <description>Incidence rate of transient ischaemic attack (TIA) on on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
          <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4859"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" lower_limit="0.12" upper_limit="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Transient Ischaemic Attack (TIA) - Phase III</title>
        <description>Incidence rate of transient ischaemic attack (TIA) on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
        <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
        <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase III)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
          <group group_id="O2">
            <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
            <description>Patients who were prescribed at baseline of Phase III the Vitamin K Antagonist (VKA) were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Transient Ischaemic Attack (TIA) - Phase III</title>
          <description>Incidence rate of transient ischaemic attack (TIA) on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
          <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3611"/>
                <count group_id="O2" value="4413"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" lower_limit="0.17" upper_limit="0.42"/>
                    <measurement group_id="O2" value="0.32" lower_limit="0.21" upper_limit="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Systemic Embolism (SE) - Phase II</title>
        <description>Incidence rate of systemic embolism (SE) on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
        <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
        <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase II)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Systemic Embolism (SE) - Phase II</title>
          <description>Incidence rate of systemic embolism (SE) on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
          <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4859"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" lower_limit="0.01" upper_limit="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Systemic Embolism (SE) - Phase III</title>
        <description>Incidence rate of systemic embolism (SE) on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
        <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
        <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase III)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
          <group group_id="O2">
            <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
            <description>Patients who were prescribed at baseline of Phase III the Vitamin K Antagonist (VKA) were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Systemic Embolism (SE) - Phase III</title>
          <description>Incidence rate of systemic embolism (SE) on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
          <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3611"/>
                <count group_id="O2" value="4413"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" lower_limit="0.00" upper_limit="0.09"/>
                    <measurement group_id="O2" value="0.05" lower_limit="0.01" upper_limit="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Pulmonary Embolism (PE) - Phase II</title>
        <description>Incidence rate of pulmonary embolism (PE) on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
        <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
        <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase II)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Pulmonary Embolism (PE) - Phase II</title>
          <description>Incidence rate of pulmonary embolism (PE) on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
          <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4859"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" lower_limit="0.02" upper_limit="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Pulmonary Embolism (PE) - Phase III</title>
        <description>Incidence rate of pulmonary embolism (PE) on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
        <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
        <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase III)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
          <group group_id="O2">
            <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
            <description>Patients who were prescribed at baseline of Phase III the Vitamin K Antagonist (VKA) were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Pulmonary Embolism (PE) - Phase III</title>
          <description>Incidence rate of pulmonary embolism (PE) on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
          <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3611"/>
                <count group_id="O2" value="4413"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" lower_limit="0.01" upper_limit="0.13"/>
                    <measurement group_id="O2" value="0.06" lower_limit="0.01" upper_limit="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Major Bleeding Events (MBE) - Phase II</title>
        <description>Incidence rate of major bleeding events (MBE) on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented. Major bleeding was defined as meeting one or more of the following criteria: Overt bleeding associated with a reduction in haemoglobin of at least 20 grams per liter or leading to a transfusion of at least 2 units of blood or packed cells; Symptomatic bleeding in a critical area or organ: Intraocular, intracranial, intraspinal or intramuscular with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding or pericardial bleeding; Life-threatening bleeding.</description>
        <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
        <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase II)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Major Bleeding Events (MBE) - Phase II</title>
          <description>Incidence rate of major bleeding events (MBE) on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented. Major bleeding was defined as meeting one or more of the following criteria: Overt bleeding associated with a reduction in haemoglobin of at least 20 grams per liter or leading to a transfusion of at least 2 units of blood or packed cells; Symptomatic bleeding in a critical area or organ: Intraocular, intracranial, intraspinal or intramuscular with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding or pericardial bleeding; Life-threatening bleeding.</description>
          <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4859"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.97" lower_limit="0.76" upper_limit="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Major Bleeding Events (MBE) - Phase III</title>
        <description>Incidence rate of major bleeding events on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. Major bleeding was defined as meeting one or more of the following criteria: Overt bleeding associated with a reduction in haemoglobin of at least 20 grams per liter or leading to a transfusion of at least 2 units of blood or packed cells; Symptomatic bleeding in a critical area or organ: Intraocular, intracranial, intraspinal or intramuscular with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding or pericardial bleeding; Life-threatening bleeding.</description>
        <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
        <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase III)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
          <group group_id="O2">
            <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
            <description>Patients who were prescribed at baseline of Phase III the Vitamin K Antagonist (VKA) were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Major Bleeding Events (MBE) - Phase III</title>
          <description>Incidence rate of major bleeding events on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. Major bleeding was defined as meeting one or more of the following criteria: Overt bleeding associated with a reduction in haemoglobin of at least 20 grams per liter or leading to a transfusion of at least 2 units of blood or packed cells; Symptomatic bleeding in a critical area or organ: Intraocular, intracranial, intraspinal or intramuscular with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding or pericardial bleeding; Life-threatening bleeding.</description>
          <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3611"/>
                <count group_id="O2" value="4413"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.69" lower_limit="0.51" upper_limit="0.89"/>
                    <measurement group_id="O2" value="1.44" lower_limit="1.20" upper_limit="1.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A multivariable Cox regression model was performed including variables of treatment, age, gender, prior bleed, previous myocardial infarction, abnormal kidney function, concomitant antiplatelets use and concomitant use of drugs related to bleeding.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.52</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.38</ci_lower_limit>
            <ci_upper_limit>0.73</ci_upper_limit>
            <estimate_desc>Hazard ratio of dabigatran versus vitamin K antagonist (vitamin K antagonist as reference).</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Life-threatening Bleeding Events - Phase II</title>
        <description>Incidence rate of life-threatening bleeding events on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented. Life-threatening bleeding was defined as meeting one or more of the following criteria: Symptomatic intracranial bleed; Reduction in haemoglobin of at least 50 grams per liter; Transfusion of at least 4 units of blood or packed cells, associated with hypotension requiring the use of intravenous inotropic agents; Necessitated surgical intervention; Fatal bleeding.</description>
        <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
        <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase II)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Life-threatening Bleeding Events - Phase II</title>
          <description>Incidence rate of life-threatening bleeding events on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented. Life-threatening bleeding was defined as meeting one or more of the following criteria: Symptomatic intracranial bleed; Reduction in haemoglobin of at least 50 grams per liter; Transfusion of at least 4 units of blood or packed cells, associated with hypotension requiring the use of intravenous inotropic agents; Necessitated surgical intervention; Fatal bleeding.</description>
          <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4859"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.46" lower_limit="0.32" upper_limit="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Life-threatening Bleeding Events - Phase III</title>
        <description>Incidence rate of life-threatening bleeding events on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. Life-threatening bleeding was defined as meeting one or more of the following criteria: Symptomatic intracranial bleed; Reduction in haemoglobin of at least 50 grams per liter; Transfusion of at least 4 units of blood or packed cells, associated with hypotension requiring the use of intravenous inotropic agents; Necessitated surgical intervention; Fatal bleeding.</description>
        <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
        <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase III)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
          <group group_id="O2">
            <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
            <description>Patients who were prescribed at baseline of Phase III the Vitamin K Antagonist (VKA) were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Life-threatening Bleeding Events - Phase III</title>
          <description>Incidence rate of life-threatening bleeding events on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only. Life-threatening bleeding was defined as meeting one or more of the following criteria: Symptomatic intracranial bleed; Reduction in haemoglobin of at least 50 grams per liter; Transfusion of at least 4 units of blood or packed cells, associated with hypotension requiring the use of intravenous inotropic agents; Necessitated surgical intervention; Fatal bleeding.</description>
          <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3611"/>
                <count group_id="O2" value="4413"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.47" lower_limit="0.32" upper_limit="0.63"/>
                    <measurement group_id="O2" value="1.07" lower_limit="0.86" upper_limit="1.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Myocardial Infarction (MI) - Phase II</title>
        <description>Incidence rate of myocardial infarction (MI) on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
        <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
        <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase II)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Myocardial Infarction (MI) - Phase II</title>
          <description>Incidence rate of myocardial infarction (MI) on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
          <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4859"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.50" lower_limit="0.35" upper_limit="0.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Myocardial Infarction (MI) - Phase III</title>
        <description>Incidence rate of myocardial infarction on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
        <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
        <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase III)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
          <group group_id="O2">
            <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
            <description>Patients who were prescribed at baseline of Phase III the Vitamin K Antagonist (VKA) were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Myocardial Infarction (MI) - Phase III</title>
          <description>Incidence rate of myocardial infarction on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
          <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3611"/>
                <count group_id="O2" value="4413"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" lower_limit="0.27" upper_limit="0.55"/>
                    <measurement group_id="O2" value="0.53" lower_limit="0.38" upper_limit="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A multivariable Cox regression model was performed including variables of treatment, age, gender, prior bleed, previous myocardial infarction, concomitant antiplatelets use, concomitant use of drugs related to bleeding, hypertension, and diabetes.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.97</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.60</ci_lower_limit>
            <ci_upper_limit>1.57</ci_upper_limit>
            <estimate_desc>Hazard ratio of dabigatran versus vitamin K antagonist (vitamin K antagonist as reference).</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of All-cause Death - Phase II</title>
        <description>Incidence rate of all-cause death on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
        <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
        <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase II)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of All-cause Death - Phase II</title>
          <description>Incidence rate of all-cause death on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
          <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4859"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.48" lower_limit="2.13" upper_limit="2.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of All-cause Death - Phase III</title>
        <description>Incidence rate of all-cause death on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
        <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
        <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase III)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
          <group group_id="O2">
            <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
            <description>Patients who were prescribed at baseline of Phase III the Vitamin K Antagonist (VKA) were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of All-cause Death - Phase III</title>
          <description>Incidence rate of all-cause death on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
          <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3611"/>
                <count group_id="O2" value="4413"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.16" lower_limit="1.84" upper_limit="2.48"/>
                    <measurement group_id="O2" value="3.57" lower_limit="3.19" upper_limit="3.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A multivariable Cox regression model was performed including variables of treatment, age, gender, prior bleed, previous stroke/transient ischaemic attack/systemic embolism, previous myocardial infarction, abnormal kidney function and concomitant antiplatelets use.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.66</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.54</ci_lower_limit>
            <ci_upper_limit>0.80</ci_upper_limit>
            <estimate_desc>Hazard ratio of dabigatran versus vitamin K antagonist (vitamin K antagonist as reference).</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Vascular Death - Phase II</title>
        <description>Incidence rate of vascular death on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
        <time_frame>From baseline visit of Phase II until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 2 years.</time_frame>
        <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase II)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Vascular Death - Phase II</title>
          <description>Incidence rate of vascular death on all eligible patients excluding prescribed but not taken set that included Dabigatran etexilate (DE) of phase II only is presented.</description>
          <population>All eligible patients who were prescribed DE at baseline in phase II excluding prescribed but not taken. All eligible: All patients who were enrolled and eligible (i.e. did not have any important. protocol violation(s) and who met certain data cleaning requirements).</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4859"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" lower_limit="0.65" upper_limit="1.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence Rate of Vascular Death - Phase III</title>
        <description>Incidence rate of vascular death on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
        <time_frame>From baseline visit of phase III until end of initial treatment regimen episode (minimum date of permanent stop of DE + 3 days/ VKA+ 6 days, start date of other treatments - 1 day, and date of study completion/discontinuation), up to 3 years.</time_frame>
        <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
        <group_list>
          <group group_id="O1">
            <title>Dabigatran Etexilate - Baseline (Phase III)</title>
            <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase III were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
          <group group_id="O2">
            <title>Vitamin K Antagonist (VKA) - Baseline (Phase III)</title>
            <description>Patients who were prescribed at baseline of Phase III the Vitamin K Antagonist (VKA) were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments may used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence Rate of Vascular Death - Phase III</title>
          <description>Incidence rate of vascular death on restricted set that included Dabigatran etexilate (DE) of phase III and Vitamin K Antagonist (VKA) of phase III only.</description>
          <population>Restricted patient set: was defined only for eligible dabigatran and vitamin K antagonist patients (pts) of phase III who were within region of propensity score (PS) overlap excluding pts in non-overlapping tails of PS distribution, using cut-offs at 1.5th percentile of the PS distribution for dab-exposed group, and 98.5th percentile of distribution for VKA-exposed group. Excluding these pts from the tails of PS distribution reduces channeling bias and improves the validity of comparisons.</population>
          <units>Events per 100 person-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3611"/>
                <count group_id="O2" value="4413"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.75" lower_limit="0.56" upper_limit="0.95"/>
                    <measurement group_id="O2" value="1.26" lower_limit="1.03" upper_limit="1.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Phase (Ph) II: From baseline visit of Phase II until Phase II completion or discontinuation, up to 2 years of follow-up. Only patients who were prescribed Dabigatran etexilate at baseline of Phase II were followed up. Phase III: From baseline visit of Phase III until study completion or discontinuation, up to 3 years of follow-up for all patients irrespective of their antithrombotic treament.</time_frame>
      <desc>Enrolled+treated: Patients(pts) entered electronic data system who signed informed consent+treated at least once with study treatments(trt). Only trt-related AEs collected +reported according to protocol-specified requirements. PhII: only AEs for pts who presribed DE at baseline collected+reported. PhIII:&quot;Combinations of oral anticoagulants at baseline&quot; excluded as no specific trt could be defined for AEs that occurred on trt interval on which they were on combination of oral anticoagulants.</desc>
      <group_list>
        <group group_id="E1">
          <title>Dabigatran Etexilate - Baseline (Phase II)</title>
          <description>Patients who were prescribed Dabigatran etexilate at baseline of Phase II were included in this group. Patients could take other Antithrombotic treatments later during the study.&#xD;
Patients who were newly diagnosed non-valvular Atrial Fibrillation (AF) less than 3 months before the baseline visits (less than 4.5 months before baseline visit for Latin America) and who were at risk for stroke in a real-life setting. Antithrombotic treatments were used according to local practice for stroke prevention. The choice of antithrombotic agent and dosing was at the discretion of the treating physician.</description>
        </group>
        <group group_id="E2">
          <title>Dabigatran Etexilate - at Least Once During Phase III of the Study</title>
          <description>All patients who received at least once dabigatran etexilate during phase III of the study were included in the group. Adverse events which happened when the patients received dabigatran etexilate were reported in this group.&#xD;
Patients can take any Antithrombotic treatments during phase III of the study. Adverse events were reported in the treatment group a patient actually received when the adverse events happened. Hence, the treatment groups in the adverse events section are not mutually exclusive.</description>
        </group>
        <group group_id="E3">
          <title>Vitamin K Antagonist (VKA) - at Least Once During Phase III of the Study</title>
          <description>All patients who received at least once Vitamin K Antagonist (VKA) during phase III of the study were included in the group. Adverse events which happened when the patients received Vitamin K Antagonist (VKA) were reported in this group.&#xD;
Patients can take any Antithrombotic treatments during phase III of the study. Adverse events were reported in the treatment group a patient actually received when the adverse events happened. Hence, the treatment groups in the adverse events section are not mutually exclusive.</description>
        </group>
        <group group_id="E4">
          <title>Rivaroxaban - at Least Once During Phase III of the Study</title>
          <description>All patients who received at least once Rivaroxaban during phase III of the study were included in the group. Adverse events which happened when the patients received Rivaroxaban were reported in this group.&#xD;
Patients can take any Antithrombotic treatments during phase III of the study. Adverse events were reported in the treatment group a patient actually received when the adverse events happened. Hence, the treatment groups in the adverse events section are not mutually exclusive.</description>
        </group>
        <group group_id="E5">
          <title>Apixaban - at Least Once During Phase III of the Study</title>
          <description>All patients who received at least once Apixaban during phase III of the study were included in the group. Adverse events which happened when the patients received Apixaban were reported in this group.&#xD;
Patients can take any Antithrombotic treatments during phase III of the study. Adverse events were reported in the treatment group a patient actually received when the adverse events happened. Hence, the treatment groups in the adverse events section are not mutually exclusive.</description>
        </group>
        <group group_id="E6">
          <title>Edoxaban - at Least Once During Phase III of the Study</title>
          <description>All patients who received at least once Edoxaban during phase III of the study were included in the group. Adverse events which happened when the patients received Edoxaban were reported in this group.&#xD;
Patients can take any Antithrombotic treatments during phase III of the study. Adverse events were reported in the treatment group a patient actually received when the adverse events happened. Hence, the treatment groups in the adverse events section are not mutually exclusive.</description>
        </group>
        <group group_id="E7">
          <title>Acetylsalicylic Acid (ASA) - at Least Once During Phase III of the Study</title>
          <description>All patients who received at least once Acetylsalicylic acid (ASA) during phase III of the study were included in the group. Adverse events which happened when the patients received Acetylsalicylic acid (ASA) were reported in this group.&#xD;
Patients can take any Antithrombotic treatments during phase III of the study. Adverse events were reported in the treatment group a patient actually received when the adverse events happened. Hence, the treatment groups in the adverse events section are not mutually exclusive.</description>
        </group>
        <group group_id="E8">
          <title>Antiplts Other Than ASA - at Least Once During Phase III of the Study</title>
          <description>All patients who received at least once Antiplts other than ASA during phase III of the study were included in the group. Adverse events which happened when the patients received Antiplts other than ASA were reported in this group.&#xD;
Patients can take any Antithrombotic treatments during phase III of the study. Adverse events were reported in the treatment group a patient actually received when the adverse events happened. Hence, the treatment groups in the adverse events section are not mutually exclusive.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>22.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="184" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="199" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="465" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="292" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="392" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="23" subjects_at_risk="686"/>
                <counts group_id="E7" subjects_affected="469" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="46" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="985" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="118" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="296" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="185" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="217" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="16" subjects_at_risk="686"/>
                <counts group_id="E7" subjects_affected="225" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="19" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="19" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="19" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Blood loss anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Eosinophilia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hypochromic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Splenic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haemorrhagic disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Normochromic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Splenic lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="159" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Atrial thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="67" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiac ventricular thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy alcoholic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hypertensive cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pericardial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Bradyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiomegaly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Left ventricular hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Myocardial fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Nodal arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pericarditis constrictive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Prinzmetal angina</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Sinoatrial block</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Sinus arrest</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Haemorrhagic arteriovenous malformation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hypertrophic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Thyroid mass</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Retinal artery embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Retinal vascular occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Open angle glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Optic ischaemic neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Abdominal wall haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Acute abdomen</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Anal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Barrett's oesophagus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Diarrhoea haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Discoloured vomit</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Duodenal varices</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastroduodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="36" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="26" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="43" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastrointestinal polyp haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastrointestinal vascular malformation haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Large intestinal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="21" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="20" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Mesenteric artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Mesenteric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Peritoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="8" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Rectal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Small intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="9" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Vomiting projectile</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Abdominal incarcerated hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Anal fissure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Chronic gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Diaphragmatic hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Faeces discoloured</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Large intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Rectal prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Tongue haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Tooth pulp haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Medical device site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Multiple organ dysfunction syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Puncture site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Suprapubic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Vessel puncture site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Catheter site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="48" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Multiple organ dysfunction syndrome</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Organ failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Drug-induced liver injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hepatic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Acute hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Biliary dyskinesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Chronic hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hepatic congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Diverticulitis intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haematoma infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Infectious pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Lung abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Clostridium difficile infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Echinococciasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Endocarditis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Endophthalmitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Lyme disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Paraspinal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pneumonia haemophilus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Post procedural sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Septic arthritis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Streptococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Extradural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Post procedural haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Splenic injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Subcutaneous haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Tongue injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Traumatic haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Traumatic haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Traumatic intracranial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Traumatic liver injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Traumatic renal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Wound haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Abdominal injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Electric shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Face injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Intestinal anastomosis complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pocket erosion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Procedural shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Skin abrasion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Tendon injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Wound secretion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Anticoagulation drug level above therapeutic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Anticoagulation drug level below therapeutic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Bleeding time prolonged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Blood urine present</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Catheterisation cardiac</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Liver function test increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Occult blood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>C-reactive protein increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT prolonged</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Glomerular filtration rate decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haematocrit decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Troponin increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hyperlipidaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Fluid retention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hyperglycaemic hyperosmolar nonketotic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Metabolic disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Compartment syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Groin pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haematoma muscle</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Muscle haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Dupuytren's contracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Vertebral foraminal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Adenocarcinoma of colon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastrointestinal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Sarcomatoid carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Acute leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Endometrial adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gallbladder adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Gastrointestinal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Glioblastoma multiforme</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage IV</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Malignant genitourinary tract neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Malignant pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Malignant respiratory tract neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Plasma cell myeloma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Prostatic adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Rectal cancer stage IV</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Basal ganglia haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Brain injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Brain stem haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cerebellar haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cerebellar stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cerebral haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Generalised tonic-clonic seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haemorrhagic transformation stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Intracranial haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Intraventricular haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ischaemic cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Vascular dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Autonomic nervous system imbalance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Brain stem infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cerebrovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Complex regional pain syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Encephalitis autoimmune</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Intracranial mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Lacunar stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Motor dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Spinal cord haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device battery issue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Device loosening</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Aggression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Derailment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Homicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Restlessness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Sleep disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Stress</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cystitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haemorrhage urinary tract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hypertensive nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Renal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Renal infarct</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Renal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ureterolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Urogenital haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Renal aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Tubulointerstitial nephritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Uterine haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Breast hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="8" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Respiratory tract haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pneumothorax spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Pulmonary sarcoidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Respiratory disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haemorrhage subcutaneous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Cold sweat</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Alcoholic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Arterial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Embolism arterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Subgaleal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Venous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Peripheral artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
              <event>
                <sub_title>Peripheral venous disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="636"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4943"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4477"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5894"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="5177"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="6024"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="686"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="6263"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="780"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Phase II part of 1160.129 includes Phase II data from 1160.129, 1160.136 and 1160.171.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Boehringer Ingelheim, Call Center</name_or_title>
      <organization>Boehringer Ingelheim</organization>
      <phone>1-800-243-0127</phone>
      <email>clintriage.rdg@boehringer-ingelheim.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

